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AEFI	 adverse events following immunization
APOA	 Annual Plan of Action
CDC	 Centers for Disease Control and Prevention
CHD	 Child Health Days
cMYP	 comprehensive multi-year plan 
DoV	 Decade of Vaccine
DQS	 data quality self-assessments
DTP	 diphtheria-tetanus-pertussis vaccine
DTP3c	 third dose of diphtheria-tetanus-pertussis containing vaccine
EPI	 Expanded Programme of Immunization
EVM	 Effective Vaccine Management assessment
Gavi	 Global Alliance for Vaccines and Immunization
GRISP	 Global Routine Immunization Strategies and Practices
GVAP	 Global Vaccine Action Plan
HBR	 home-based records
HIV	 Human Immunodeficiency Virus
ICC	 Interagency Coordinating Committee
IIP	 Immunization in Practice 
IPAC	 Immunization Practices Advisory Committee
IVIRAC	 Immunization and Vaccines related Implementation Research Advisory Committee
KAP	 knowledge, attitude and practices
M&E	 monitoring & evaluation
MLM	 mid-level management training
MNT	 maternal and neonatal tetanus
MNTE	 Maternal and Neonatal Tetanus Elimination
NITAG	 National Immunization Technical Advisory Group
PATH	 Program for Appropriate Technology in Health
PIE	 post-introduction evaluation
PIRI	 Periodic Intensification of Routine Immunization
PQS	 Performance, Quality and Safety
PSPQ	 Programmatic Suitability for Prequalification
RITAG	 Regional Immunization Technical Advisory Group
SAGE	 Strategic Advisory Group of Experts
SIA	 Supplementary Immunization Activity
UNICEF	 United Nations Children’s Fund
VPD	 vaccine-preventable disease


















































































































CHAPTER 1 EXECUTIVE SUMMARY
1. EXECUTIVE  
SUMMARY
Immunizations are among the most successful and cost-effective health interventions ever devised. 
They have reduced child deaths and disease prevalence radically. They have enabled the eradication 
of smallpox, lowered the global incidence of polio by more than 99% and neonatal tetanus by 
94%, and achieved dramatic reductions in illness, disability and death from common childhood 
diseases. However, global mobility and interdependence have increased the vulnerability of people 
everywhere to the uncontrolled spread of diseases through epidemics. 
To realize the full benefits of immunization, the Global Vaccine Action Plan 2011–2020 (GVAP), 
endorsed by the World Health Assembly in May 2012, sets the direction for a “Decade of Vaccines” 
through delivery of universal access to immunization. However, routine immunization, which is 
integral to achieving this vision, is in need of a cohesive delivery and advocacy platform globally. 
There is also an absence of a commonly agreed upon routine immunization mission statement 
within disease-specific initiatives, leading to the global immunization financing architecture being 
very unbalanced, focusing primarily on disease control projects and vaccine introductions, and 
less so on the required systems strengthening and extension of the reach of sustainable, equitable 
routine immunization.
The term “routine immunization” is understood in two distinct ways that relate to the foundation of 
the health system and activities to improve equitable coverage, as described in the table below. It is 
important to distinguish between these perspectives, as many activities to sustainably strengthen 
routine immunization systems may not result in short-term or rapid improvements in immunization 
coverage. Equally, many activities specifically designed to rapidly increase routine immunization 
coverage may not result in the long-term strengthening and sustainability of the programme.
The purpose of GRISP is to reassert routine immunization as the foundation for sustained decreases 
in morbidity and mortality from vaccine-preventable diseases across the life-cycle of all individuals. 
Its objectives are:
◆◆ to contribute to countryefforts towards sustained routine immunization programmes;
◆◆ to setglobalpriorities in the attainment of immunization for all persons targeted;
◆◆  to ensure global, regional and country coordination among immunization partners and 
stakeholders in routine immunization activities and plans;
◆◆  to align new vaccine introduction, accelerated disease control and prevention and programme 
monitoring activities with a jointgoalofroutineimmunizationprogrammesupport, both in 














































GRISP contains two components namely nine  transformative  investments  to  achieving  better 
immunization  outcomes and a  comprehensive  framework  of  strategies  and  practices  for 
routine immunization.
1.1.  Nine transformative investments to achieving better 
immunization outcomes
These aim to provide overall direction and, if implemented, will transform national programmes and 
the work of global partners, enabling us to reach the stated DoV goals. These investments are a call 
to action to governments, donors and partners and should be seen as the highlights and priorities 





































































CHAPTER 1 EXECUTIVE SUMMARY
1.2.  A comprehensive framework of strategies and 
practices for routine immunization 
Implementing the strategies and practices within this framework will strengthen routine 
immunization systems and improve coverage. In addition, the framework organizes them by four 
main areas of action, enabling a systematic approach to be taken.
  Detect and reach the unreached
  Design services to reach all equitably
   Build capacity of vaccinators  
and managers
  Ensure vaccine quality and availability
●   Create synergy with special  
vaccination efforts
●  Integrate immunization services
MAXIMIZE 
REACH
●   Secure political commitment  
and partnerships
   Plan, budget and mobilize resources
   Ensure excellence in national leadership
●  Set programme policy and guidance
MANAGE the 
PROGRAMME
●   Engage communities and create demand
   Mobilize and communicate  
for vaccination




   Monitor programme performance  
& disease occurrence




Coloured dots designate transformative investment strategies.
GRISP, as a companion document to the GVAP does not have a separate monitoring and evaluation 













































































































Immunizations are among the most successful and cost-effective health interventions ever devised. 
They have reduced child deaths and disease prevalence radically. They have enabled the eradication 
of smallpox, lowered the global incidence of polio by more than 99% and neonatal tetanus by 94%, 
and achieved dramatic reductions in illness, disability and death from measles, diphtheria, pertussis, 
hepatitis B, rotavirus, yellow fever and invasive bacterial causes of pneumonia and meningitis. They 
are predicted to continue to have an enormous impact on public health (see Table 1).
Table	1. Forecast impact of vaccination administered in the routine programme, 2011–2020  










Measles – first dose 10 600 16.5










Human papillomavirus 500 15.1
Yellow fever 30–40 0.2
Total 20 630–21 940
*  Meningococcal meningitis A, Japanese encephalitis and rubella excluded as the calculation was for combined routine and 
campaign delivery.
Nevertheless, global mobility and interdependence have increased the vulnerability of people 
everywhere to the uncontrolled spread of diseases through epidemics. Rises in measles and diphtheria 
cases in areas previously thought to be rid of these diseases have shown that in spite of dramatic 
reductions of vaccine-preventable diseases (VPDs), risks from these diseases remain and increasing 
complacency may lead to disease resurgence. The threat of an influenza pandemic in 2009 and the West 
African Ebola outbreak in 2014 highlight the need to strengthen country ownership and international 
solidarity, mutual support and partnerships to contribute to improving global health and security as 
well as achieving universal health coverage. To fully reap the benefits of immunization, high levels of 
vaccine coverage must be achieved and maintained; people must be vaccinated correctly and safely 
at optimal ages with potent vaccine; services must be extended to people currently unreached and 
to age groups beyond infancy; new vaccines and technologies must be introduced; and vaccination 














































In response to immunization needs worldwide, global partnerships, such as Gavi, the Vaccine 
Alliance, the Global Polio Eradication Initiative, the Measles Rubella Initiative and the Maternal and 
Neonatal Tetanus Elimination (MNTE) partnership, strive for synergies to achieve shared outcomes. 
These global partnerships all have as their core strategies – in line with reaching their own goals – the 
strengthening of routine immunization systems and increasing coverage. They bring together major 
stakeholders in immunization from the public and private sectors, including the vaccine industry.
To realize the full benefits of immunization, the Global Vaccine Action Plan 2011–20201 (GVAP), endorsed 
by the World Health Assembly in May 2012, sets the direction for a “Decade of Vaccines” through 
delivery of universal access to immunization (see section 2.3). However, routine immunization, which 
is integral to achieving this vision, is in need of a cohesive delivery and advocacy platform globally. 
There is also an absence of a commonly agreed upon routine immunization mission statement 
within disease-specific initiatives, leading to the global immunization financing architecture being 
very unbalanced, focusing on disease control projects and vaccine introductions, but less so on the 
required systems strengthening and extension of the reach of routine immunization.
To build on the undisputed past successes of immunization and realize its promising future, global 
partners must ensure that routine immunization coverage, equity and the actual delivery of vaccines 
to hard-to-reach populations remain high on the global health agenda by raising awareness of their 
importance, benefits and synergies among governments, donors and the global health community 
as a whole. The persistence of too much vaccine-preventable morbidity and mortality underscores 
the need to redouble efforts to continuously improve the quality and reach of immunization 
service delivery.
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The 2014 Decade of Vaccines progress report2 highlights the need to intensify efforts, given its 
statement that: “By 2014, one third of the world’s 194 countries are not achieving the GVAP goal of 
90% DTPc3 [third dose of diphtheria-tetanus-pertussis containing vaccine] national coverage and 
this has been the case for the preceding 4 years” (see Figure 1). An enhanced routine immunization 
approach is described below.
1   World Health Organization. Global vaccine action plan 2011–2020. ISBN 978 92 4 150498 0   
http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/















































2.2.  Purpose of the Global Routine Immunization 
Strategies and Practices (GRISP)
This document constitutes the recommendation of WHO and global immunization partners 
working in immunization regarding the routine immunization activities required to be undertaken 
to reach the GVAP goals. It is a result of a collaboration among major stakeholders in this field. 
The ongoing oversight of activities resulting from this document will be coordinated by the World 
Health Organization (WHO) and overseen by the WHO Strategic Advisory Group of Experts (SAGE) for 
immunization, with follow-up conducted in line with the GVAP reporting. 
The purpose of GRISP is:
To reassert routine immunization as the foundation  
for sustained decreases in morbidity and mortality  
from vaccine-preventable diseases across the life-cycle  
of all individuals.
Its objectives are:
◆◆ to contribute to countryefforts towards sustained routine immunization programmes;
◆◆ to setglobalpriorities in the attainment of immunization for all persons targeted;
◆◆  to ensure global, regional and country coordination among immunization partners and 
stakeholders in routine immunization activities and plans;
◆◆  to align new vaccine introduction, accelerated disease control and prevention and programme 
monitoring activities with a jointgoalofroutineimmunizationprogrammesupport, both in 














































2.3.  The Global Vaccine Action Plan 2011–2020:  
Achieving the Decade of Vaccines vision
The GVAP builds on the success of the Global Immunization Vision and Strategy 2006–2015, 
which was launched in 2005 as the first 10-year strategic framework to realize the potential of 
immunization. Its development brought together multiple stakeholders involved in immunization 
– including governments and elected officials, health professionals, academics, manufacturers, 
global agencies, development partners, civil society, media and the private sector – to collectively 
define what the global community wants to achieve in immunization over the next decade. 
The GVAP reiterates existing goals, sets new ones, proposes six strategic objectives and the actions 
that will support their achievement, and provides an initial estimate of resource requirements and 
return on investment. Country, regional and global stakeholders are responsible for specific actions 
in translating the GVAP into detailed operational plans, monitoring and evaluating progress, and 
mobilizing resources to ensure the Decade of Vaccines vision becomes a reality.
This section reviews the Decade of Vaccines vision and GVAP mission as GRISP fully subscribes to 
these and proposes strategies and activities for their realization further below.
2.3.1. Decade of Vaccines Vision and GVAP Mission
The Decade of Vaccines (2011–2020) vision is:
A world in which all individuals and communities  
enjoy lives free from vaccine-preventable diseases.
The GVAP mission is:
To extend, by 2020 and beyond, the full benefit  
of immunization to all people, regardless of where  
they are born, who they are or where they live.
2.3.2. GVAP Guiding Principles
GRISP adheres to the six GVAP guiding principles in all aspects:
◆◆  Countryownership – countries have primary ownership and responsibility for establishing 
good governance and for providing effective and quality immunization services for all.
◆◆  Shared responsibility and partnership – immunization against vaccine-preventable 
diseases is an individual, community and governmental responsibility that transcends 
borders and sectors.
◆◆ Equity – equitable access to immunization is a core component of the right to health.
◆◆  Integration – strong immunization systems, as part of broader health systems and 
closely coordinated with other primary health care delivery programmes, are essential 
for achieving immunization goals.
◆◆ Sustainability – informed decisions and implementation strategies, appropriate levels 
of financial investment, and improved financial management and oversight are critical 
to ensuring the sustainability of immunization programmes.
◆◆  Innovation – the full potential of immunization can only be realized through learning, 
continuous improvement and innovation in research and development, as well as 














































2.3.3. Decade of Vaccines goals
The GVAP is a plan to achieve the goals that the international immunization community 
has given itself for the Decade of Vaccines (2011–2020), and incorporates and expands on 
previously articulated goals. All DoV goals require a well-functioning immunization system, 
and increasing routine immunization coverage. The goals were articulated and agreed in 
GVAP and are repeated here:
◆◆ Achieve a world free of poliomyelitis
◆ By 2014, interrupt wild poliovirus transmission globally
◆ By 2018, certification of poliomyelitis eradication
◆◆ Meet global and regional elimination targets
◆ 2015: Neonatal tetanus eliminated in all WHO regions
◆ 2015: Measles eliminated in at least four WHO regions
◆  2015: Rubella/congenital rubella syndrome eliminated in at least two WHO regions






◆◆ Develop and introduce new and improved vaccines and technologies
◆  2015: At least 90 low-income and middle-income countries have introduced one or 
more new or underutilized vaccines
◆  2020: All low-income and middle-income countries have introduced one or more new 
or underutilized vaccines
◆  2020: Licensure and launch of vaccine or vaccines against one or more major currently 
non-vaccine-preventable diseases
◆ 2020: Licensure and launch of at least one delivery platform technology
◆◆ Exceed the Millennium Development Goal 4 target for reducing child mortality
◆  2015: Reduce by two thirds, between 1990 and 2015, the under-five mortality rate 
(Target 4.A)
◆  2020: Exceed Millennium Development Goal 4 Target 4.A for reducing child mortality
Reaching the coverage targets indicated in bold text above stand out as key aims of this 
document. However, as the foundation to all immunization activities, routine immunization 
will play a major role in the attainment of all of these DoV goals. In some cases, as the targets 
for 2015 may be unreachable in the short time frame left, emphasis should be placed on 














































2.4.  “Routine immunization” – one term, two perspectives: 
immunization system strengthening and coverage 
improvement
The immunization system, as part of a functioning health system, is the foundation for achieving 
and sustaining coverage targets, successfully introducing new vaccines and sustainably reducing 
or eliminating vaccine-preventable disease and mortality. Like all preventive health programmes, 
the immunization programme has to be aligned with the broader health system, and as such has to 
conform with the universal health coverage concept promoted by WHO, and to the principles of the 
International Health Partnership (IHP)+ platform.
Despite their relative maturity, immunization programmes in many countries may have become 
stressed as they face new challenges: many programmes struggle to cope with the demands of 
increasing population, immunization coverage stagnation, effective and efficient management of 
resources, new vaccine introduction, accelerated disease control efforts and inadequate resources. 
These increased demands on resources and support systems have not increased in step with the 
introduction of new vaccines. Programmes require policies and guidelines, staff, supplies, logistics, 
management, accurate monitoring and surveillance, community engagement, political ownership, 
financial support, communications, advocacy, and coordination. Constant support, attention, 
maintenance and repair or revision are needed for achieving sustained, effective and efficient 
performance to ensure that all targeted persons are fully immunized with the current recommended 
range of vaccines. Past high accomplishment does not guarantee success in the future.
As an integral part of the health system, immunization service delivery can be viewed as a 
developmental challenge that requires a systems approach at all relevant administrative levels. The 
many interconnected components of an immunization system require multi-disciplinary attention 
to build a cohesive, non-fragmented and well-performing programme. Certain components 
may have been neglected for a variety of reasons, including institutional preferences of partner 
agencies, formulaic prescriptions and the absence of a learning culture that identifies and diffuses 
innovative ideas.
The term “routine immunization” is understood in two distinct ways that relate to the foundation of 














































to distinguish between these perspectives, as many activities to strengthen routine immunization 
systems may not result in short-term or rapid improvements in immunization coverage. Equally, 
many activities specifically designed to rapidly increase routine immunization coverage may not 








“Routine immunization” refers to the part of
the health system that facilitates vaccination
servicedeliverytoallthoseeligible.
The term encompasses system components 
such as:
◆◆programme planning, management  
and financing;
◆◆service implementation with adequate  
human resources, logistic support  
through relevant delivery strategies  
and monitoring;
◆data recording and reporting;
◆◆programme communication; and
◆◆vaccine supply and management  
with quality assurance.
It is the foundation on which the entire 
programme is built and is a part of the overall 
health system of a country.
Many components of the immunization system 
are not unique to the immunization programme 
but are common to all programmes and 
components of the health system.
Within GRISP, “Securing the Foundation” is 
reflected in strategies and activities, such 
as programme leadership, human resource 
capacity building, vaccine availability and 
quality, political commitment, programme 
planning and financing, policy guidance and 
monitoring and surveillance.
“Routine immunization” may also describe the 
process to regularly deliver vaccines according 
to the national vaccination schedule, and 
specific activities	are	designed	to	boost	routine	
immunization	coverage	rapidly, to reach stated 
coverage or disease control goals. These may 
often lack long-term sustainability.
Routine immunization coverage is the 
percentage of the target group that is provided 
with the appropriate number of doses of a 
specific vaccine according to their age, and 
is a measure of the ability to reach the target 
population.
In addition to disease-specific activities and 
special projects such as the introduction of a 
new vaccine, a country’s routine immunization 
programme should implement tailored activities 
to increase routine immunization coverage 
where it is lagging.
Within GRISP, “Reaching towards Universal 
Immunization Coverage” is reflected in strategies 
and activities such as detecting and reaching 
marginalized and partially served populations, 
improving coverage equity, creating synergy 
with accelerated disease control activities, 
creating demand for vaccination, mobilizing 































































































































CHAPTER 3 WHERE SHOULD WE FOCUS OUR ATTENTION?
3. WHERE SHOULD WE FOCUS  
OUR ATTENTION?
3.1.  Nine transformative investments to achieving better 
immunization outcomes
A global strategic document such as this has to, by its nature, be comprehensive and has to outline 
a broad and complete set of strategies and activities.
However, the following nine investments are meant to give direction and will transform national 
programmes and global partners, and will enable us to successfully reach the stated DoV goals. 
These investments should be seen as the highlights and priorities of this document, and they are 
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These investments should not be seen as being in order of importance, as their importance may 
differ considerably between one country and another. However, the first investment, ensuring 
an excellent, capable and well resourced national programme team stands out as being the most 
important enabler for all other strategies and practices to succeed. In the years covered by GRISP, 














































CHAPTER 3 WHERE SHOULD WE FOCUS OUR ATTENTION?
3.2.  What routine immunization activities should be 
promoted in a particular country?
Countries differ considerably in the maturity and capacity of their immunization programmes, so 
some strategies and activities described below may be more applicable to some than to others. 
Clearly, this is a matter that has to be determined at country level. While general guidance is 
provided below, each country is encouraged to find appropriate strategies and activities to meet 
the challenge and opportunities of their situation.
Broadly, countries’ national DTPc3 immunization coverage can serve as a proxy for their routine 
immunization programme performance, taking into consideration the trend of this coverage over 
the previous few years. Similarly, a high dropout rate can point to more systemic problems that 
need systemic solutions. Also, in countries where great differences between subnational states/
regions/provinces exist, different strategies may be more successful than others.








Lessthan50% Developing health infrastructure and systems
50–79%
Operationalizing  
the programme, including supply  
chain development,  
national health financing,  
health workforce development,  
and long-term country-led  
health planning
◆Demand generation
◆◆Sharing responsibility for 
immunization with communities
◆◆Adjusting service availability and 
convenience
◆◆Offering all antigens at each 
vaccination session
◆◆Improving the quality of 
microplanning and outreaches
◆◆Avoiding missed opportunities, 
invalid doses, and late completion of 
vaccination schedules
◆◆Line listing everyone and checking 
immunization status of everyone 
targeted
◆◆Obtaining disaggregated coverage 
data at subnational and local level to 
identify and target low coverage areas. 
80–89%
Reaching all and achieving  
equity and programme quality,  
including strengthening  
of health management  
information system (HMIS)  
and surveillance, investing  
in shared responsibility  
for immunization with  
the community, equity in terms  
of gender, wealth, education, etc.
Above90%
Fine-tuning and focusing  
on marginalized and excluded  
groups and individuals still  
unreached for any reason
Creating community awareness  
and making the service more  
community oriented by removing  
social and cultural barriers
The nine highlighted transformative investments earlier in section 3 are appropriate in all countries 
and settings, and should be prioritized according to the country situation.
National leadership and programme management excellence (transformative investment) is the 
cornerstone to improving any aspect of the programme and should be prioritized in all countries. 
Similarly proper planning, funding, training, monitoring and community involvement activities are 
essential in all countries, irrespective of their coverage level.
Countries that have reached high levels of coverage and system capacity are encouraged to focus 
additional activities to target strategies to reach remaining unvaccinated individuals, and to expand 















































































































OF STRATEGIES AND PRACTICES 
FOR ROUTINE IMMUNIZATION
MAXIMIZE REACH    4.1
MANAGE the PROGRAMME    4.2
MOBILIZE PEOPLE    4.3

















































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
4. COMPREHENSIVE FRAMEWORK  
OF STRATEGIES AND PRACTICES  
FOR ROUTINE IMMUNIZATION
This section provides a comprehensive collection of strategies and practices to strengthen routine 
immunization systems and improve coverage. In addition, it organizes strategies by four main areas 
of action, enabling a systematic approach to routine immunization strategies.
This group of strategies are formulated to extend the coverage and 
reach of the programme to deliver immunization services in an 
integrated manner using opportunities that present themselves 
with special vaccination efforts such as campaigns and new vaccine 
introductions. They contain key health systems components such as 
human resources development and the provision of vaccines.
This group of strategies focus on the political support and management 
functioning of the programme. In addition to strengthening the 
capacity of the national immunization programme team, these 
strategies ensure that national policy setting and decision-making are 
adequately addressed.
These strategies emphasize the demand side of immunization services 
and encourage the building of resilient community structures and 
relationships to share the responsibility for immunization services. 
Equally they focus on addressing concerns and hesitancy about 
vaccination.
These strategies complete the framework by outlining the mechanism and 
process to ensure that the implementation of vaccination strategies 
achieves their intended results and outcomes. It combines ongoing 
monitoring through programme reporting and disease surveillance 





















































CHAPTER 4COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
Not all strategies and practices are appropriate in every country and every setting. Local knowledge, 
experience, research and guidance will be essential in selecting the appropriate strategies from this 
framework to be integrated into national strategic programme thinking.
Coloured dots designate transformative investment strategies.
COMPREHENSIVE FRAMEWORK OF ROUTINE IMMUNIZATION STRATEGIES AND PRACTICES
  Detect and reach the unreached
  Design services to reach all equitably
   Build capacity of vaccinators  
and managers
  Ensure vaccine quality and availability
●   Create synergy with special  
vaccination efforts
●  Integrate immunization services
MAXIMIZE 
REACH
●   Secure political commitment  
and partnerships
   Plan, budget and mobilize resources
   Ensure excellence in national leadership
●  Set programme policy and guidance
MANAGE the 
PROGRAMME
●   Engage communities and create demand
   Mobilize and communicate  
for vaccination




   Monitor programme performance  
& disease occurrence
















































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
 
4.1. MAXIMIZE REACH
4.1.1.  Detecting and serving unreached or marginalized 
populations, communities and individuals















National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to reach undervaccinated and unreached people.
TRANSFORMATIVEINVESTMENT
Invest in tailored strategies that identify undervaccinated and unvaccinated 
persons and regularly provide them with the vaccines they need.
Communities and individuals at risk of immunization inequities 
due to social, geographical, economic, religious and/or other 
differences should be identified and listed. This needs to be 
done at all programme levels, using programme monitoring 
data, district-level diagnostic tools and surveys. The root causes 
of why some populations or communities are undervaccinated 
or unreached should be investigated in detail. Causes may be 
as divergent as vaccine availability, health workers’ attitudes, 
service reliability, family and community health-seeking 
behaviours, lack of understanding or trust in the health system 
and vaccines, and/or physical and financial accessibility.3
Where cultural, societal or behavioural barriers to or concerns 
about immunization exist, they should be investigated in-depth. 
Following the determination of behavioural issues, context-
specific interventions should be designed and implemented to 
address the diagnosed issue.4
3  UNICEF. What Does It Take To Immunize Every Child? Achieving equity in immunization. June 2015
4   WHO European Regional Office. The Guide to Tailoring Immunization Programmes (TIP):  
























































CHAPTER 4COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
In individual health facilities, the attitude and practice of 
a single health worker may affect how clients perceive the 
services and whether clients are willing to return for follow-up. 
In some communities, gender, ethnicity and/or language 
may be important factor(s) influencing the health worker–
client interaction. In some cases, a knowledge, attitude and 
practices assessment (KAP) should be undertaken to identify 
the deficiencies in the health worker–client interaction. 
Specific supportive remedial action can be taken when issues 
are identified.5 In some communities, agreed and publically 
displayed facility scorecards have allowed for good and honest 
feedback between the community and health workers.
A consumer-oriented approach, characterized by friendliness, 
convenience, efficiency and quality of services at health facilities, 
contributes significantly to the willingness of the population to 
access them. Vaccination sessions should be designed to reduce 
long waiting times during routine immunization sessions; clear 
messages on when to return should be given. For outreach, 
prompt communication as soon as a session is cancelled 
is essential so that caregivers are not left waiting without 
services. In addition to health worker attitudes and information 
communicated, the structure and condition of the facilities are 
important, including the availability of a comfortable waiting 
area and clean toilets.
Health workers should take the opportunity to review home-
based records during any case investigation or campaign 
monitoring assessment. Any unvaccinated or undervaccinated 
children encountered should be referred to the next local 
immunization session, with clear explanation to the caregiver. 
Where community health workers or members of civil society 
conduct home visits during surveillance or campaign activities, 
these referrals should also be made known to the local facility.
Most countries have a minority of highly mobile populations that 
may be marginalized by the system or find it necessary to “hide” 
their children from the authorities, for fear of recrimination, 
repatriation (if they are immigrants or refugees), removal 
(if they are illegal squatters), rejection (if they are nomads 
from neighbouring countries), or other dire consequence. 
The immunization programme, within the broader health 
system, should investigate means to identify these children 
without triggering negative consequences and delivering basic 
preventive health services to them, if necessary anonymously. 
In some settings, civil society organizations may be deployed 
to reassure the population that information will not be shared 
with the authorities. General awareness should be raised on 
the right to health (for example in the International Covenant 
on Economic, Social and Cultural Rights), and the Convention on 
the Rights of the Child.
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4.1.2.  Improving equity and reach by designing vaccination 
services to efficiently and effectively deliver vaccines  
to all target groups














National immunization programmes, supported by all partners, should pursue the 
following GRISP strategies and activities to improve immunization coverage equity through 
immunization programme design.
6Accurate planning and execution of facility and outreach 
sessions is the most basic means for reaching all populations. 
District and facility managers should be given tools and 
skills and relevant resources to strengthen planning and 
implementation capacity. During microplanning, both fixed 
and outreach sessions should be organized according to actual 
population size, geography, community needs and quality 
of services in terms of frequency and location of sessions, 
number of vaccinators, availability of vaccines, opening hours 
and seasonal surge times and strategies to overcome security 
issues. To best serve populations through outreach and 
pulse vaccinations, sessions should be designed to rationally 
balance the need to deliver doses at specific times in a child’s 
life with the effort and cost of extended services. To best tailor 
services, microplans should be developed in collaboration with 
representatives of the served population to solicit their input 
and agreement.7
In-country advocacy and mobilization of political commitment 
aim to strengthen understanding that equitable programmes are 
essential to achieving national and international immunization 
goals. Service delivery to all people needs to be prioritized 
and sustained at all levels. Unreached populations may live in 
6   WHO/UNICEF. Microplanning for Immunization Service Delivery: Using the Reaching Every District (RED) Strategy.  
WHO/IVB/09.11. October 2009 http://www.who.int/immunization/sage/9_Final_RED_280909.pdf






















































CHAPTER 4COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
remote areas that are difficult to access physically and/or are 
insecure, but some may exist within reach of facilities due to 
other underlying issues, e.g. the urban poor, ethnic minorities 
or migrants. Facility-level issues such as limited opening hours 
that preclude attendance of working parents and caregivers 
should also be factored as appropriate.
In countries where fixed sites are inadequate for regular 
provision of preventive health services to all targeted 
individuals, the provision of outreach services should be a central 
strategy. Outreach routes and frequency and types of services 
provided should be carefully planned using, where possible, 
modern technologies such as geographical information system 
information as well as local knowledge from health workers, 
community leaders and civil society representatives. Outreach 
services must be adequately resourced with staff, funding, 
supplies, vehicles, fuel and other operational requirements to 
ensure their reliable and predictable provision.
Activities such as “child health days” are employed in some 
countries to rapidly boost routine immunization by conducting 
a campaign-like, extra-effort approach, sometimes also 
targeting mothers for tetanus toxoid vaccinations. These 
activities should be seen as part of the routine immunization 
arsenal and should be employed either in remote communities 
as extended outreach or to provide missed immunization doses 
in undervaccinated populations. This approach differs from 
disease-specific campaigns (such as measles supplemental 
immunization activities8 or polio national immunization days) 
in that PIRI activities:
◆◆  should be integrated, i.e. provide a broad set of antigens 
and other interventions based on community needs to 
boost participation;
◆◆  should provide only the missing doses as per the national 
schedule after review of home-based vaccination records 
(HBR) or facility registries and defaulter tracking and, in 
cases where no documentation exists, should provide 
the first dose in the immunization series along with 
HBR documentation and clear follow-up instructions to 
the caregiver;
◆◆  should record doses given by name and type of dose and 
vaccine, both in the HBR and facility register;
◆◆  should be targeted to communities where routine service 
delivery is too weak or unable to reach all children 
and pregnant women with routine immunization 
delivery strategies.9
8  Offering routine antigens to missed or defaulting children up to a specific age can be included along with disease specific supplementary 
immunization activities (SIAs) to boost routine immunization coverage. Such an approach has been successfully implemented in some 
countries. See “Use accelerated vaccination activities such as campaigns to actively look for and refer inadequately immunized children to 
regular vaccination sessions” below.
9  John Snow Inc. Periodic Intensification of Routine Immunization (PIRI): Lessons Learned and Implications for Action  
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National immunization programmes are encouraged to expand 
scheduled routine vaccination visits beyond the first year of life 
and to provide needed vaccines in the preschool, school and 
adolescent and adult populations in keeping with transformative 
investment. Vaccination opportunities, such as healthy child 
visits in the second year of life, preschool preparation visits and 
school visits should be utilized for assessment of vaccination 
status and administration of previously missed doses.
TRANSFORMATIVEINVESTMENT
Invest in sustainably expanding routine vaccination schedules to cover 
people’s entire lives
The provision of a dose of hepatitis B, Bacillus Calmette–Guérin 
(BCG) vaccine and, especially in polio-endemic countries, oral 
polio vaccine, should be part of the standard package of health 
services in the immediate period after birth in all health facilities, 
once the newborn has been stabilized. If needed, steps should 
be taken to ensure the availability of newborn vaccinations 24 
hours per day, 7 days per week in health facilities that attend 
births. If vaccination of the newborn before discharge from the 
health facility is not possible, the mother should be provided 
with a vaccination card for the baby and counselled about 
where and when to go for vaccination, as well as its importance. 
Provision of these birth doses should also be planned for in-home 
and non-institutional deliveries along with promotion of birth 
registration and the referral of mothers to the nearest health 
facility. Providing information to mothers during antenatal 
visits, newborn registration and a home-based record given to 
parents also help with immunization adherence and tracking.10
In most countries home-based records, e.g. vaccination cards 
or child health booklets, are cornerstones of the immunization 
programme at local level; caregivers and health workers should 
consider them to be valuable and important. Home-based 
records should be given to caregivers at every child’s first contact 
with the health system preferably at birth and reviewed at 
each interaction. National programmes should carefully design 
these forms and keep them updated to comprehensively follow 
child health needs; they should ideally be made of durable and 
waterproof materials. National programmes should assign high 
priority to providing sufficient and sustained stocks at all levels 
of the system.11 When a home-based record is lost, a replacement 
record should be given to the caregiver, ideally re-completed 
with accurate immunization data from facility-based records.
With proper facility record keeping, caregivers that should have 
returned for their child’s next vaccination (or for their own 
subsequent dose in a series), but have not, should be identified. 
Facility registers should be designed to enable rapid tracing 
10  WHO. Every Newborn Action Plan. http://www.who.int/maternal_child_adolescent/topics/newborn/enap_consultation/ en/
11   WHO. Practical guide for the design, use and promotion of home-based records in immunization programmes.  
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and contain caregivers’ contact details (e.g. physical address 
and mobile phone number). Where mobile phones are widely 
available, caregivers’ mobile phone numbers should be added 
to the register, and text messages used to remind about return 
visits after a missed visit. Defaulter tracing requires continuous 
effective interaction with the community, caregivers, community 
health workers and local civil society organizations and should 
be monitored as evidence of programme performance. If 
immunization registers at community and health facility level 
are entered with a child’s name and details at birth (organized 
with a row per child and per pregnant woman, not a row per visit), 
they enable the tracing of defaulters who did not even attend the 
first vaccination session. This will help ensure that children and 
pregnant women are tracked with other defaulters if they do not 
present for immunization sessions.12
13Unvaccinated and undervaccinated children and pregnant 
women may access health services for curative or other 
preventive services or accompany an adult seeking care, and 
such a visit becomes a “missed opportunity” if immunization is 
not addressed. Overdue doses not given at other vaccine dose 
visits are also considered missed opportunities. Health facility 
staff in both non-immunization and immunization services 
should review the vaccination status of all clients presenting 
or accompanying others and provide any missed doses. Equally, 
health workers should avoid false contraindications preventing 
the vaccination of an eligible person. Concomitantly, children and 
women coming for immunization services should also receive 
other preventive health interventions at the same time to avoid 
missed opportunities in respect of other interventions.
Private vaccinators can enhance the ability of programmes to 
deliver recommended doses, especially to clients who prefer them 
over public services. National immunization programmes should 
ensure that appropriate schedules and high-quality practices 
are implemented by private health care providers and that they 
are held to appropriate vaccine handling and storage standards. 
Should vaccines provided by the public sector be administered 
in the private sector, the vaccines should be provided free of 
charge and the private vaccinator should comply with national 
reporting requirements and approved cold chain and vaccine 
handling practices.
Health workers should be fully vaccinated in order to prevent 
nosocomial transmission of vaccine-preventable diseases. 
Academic institutions should vaccinate students during basic 
training or upon graduation, and proof of vaccination should 
be required along with academic qualifications by prospective 
employing institutions. This must be an absolute requirement 
in the case of health workers who have contact with paediatric, 
immune-compromised and intensive care patients. All health 
12  WHO. Immunization in Practice: Chapter 6: Monitoring and surveillance. http://www.who.int/immunization/documents/training/en/
13   “A missed opportunity for vaccination is defined as an occasion when a person, who is eligible for vaccination, and with no valid  
























































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
workers should be fully immunized against hepatitis B, measles, 
rubella, polio, seasonal influenza and diphtheria and tetanus.
Other occupational groups should be systematically vaccinated 
according to WHO recommendations, including people working 
with animals (e.g. rabies), and those providing emergency 
services. Where appropriate, vaccination of travellers going to 
endemic disease areas (e.g. polio, measles, and yellow fever) and 
to large social or religious gatherings (e.g. major sports events, 
Hajj) should be advocated for and implemented.
Vaccination against diseases such as measles, meningococcal 
disease, polio and cholera may be of critical importance 
preventing epidemics among refugees and displaced persons. 
Basic tally sheets and finger marking may be used instead of 
home-based records to record the doses given in emergencies. 
National programme managers should review the WHO guideline 
on “Immunization in emergency” and include immunizations in 
emergency contingency plans. Equally, as immunization services 
may be suspended during an emergency, rapid resumption of 
basic primary health services, including immunization, should 
be included in post-emergency contingency plans.14





































































National immunization programmes, supported by all partners, should pursue the following 
listed GRISP strategies and activities to build vaccinator and peripheral manager capacity 
and motivation.
The quality of an immunization programme depends on its 
ability to ensure that the knowledge and skills of its vaccinators 
and peripheral managers are up to date. Regular monthly 
meetings for data review or management oversight provide 
a good opportunity to update health workers on new policies 
and to refresh previous training and solicit feedback from them 
on their constraints. Regular in-service training sessions and 
opportunities for self- and on-the-job learning (such as use of 
the Immunization Service Checklist) have to be planned and 
systematically implemented for all staff. Attention to increased 
training needs in times of rapid change, e.g. introduction 
of new vaccines or a new strategy, is essential especially in 
programmes where staff turnover is high. Attention to quality 
through standard training materials and measuring and 
monitoring trainees’ scores on standardized knowledge tests 
is also essential, particularly in programmes using a cascade 
training approach where some staff are trained at national 
level to subsequently train peripheral levels, thereby risking 
loss or distortion of key training content. Access to training 
opportunities should be ensured.
TRANSFORMATIVEINVESTMENT 
Invest in vaccinators and district managers by regularly and systematically 
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Unless health workers are motivated to conduct their work with 
excellence, programme improvement efforts will fail. Motivation 
not only requires opportunities for training, mentoring and 
career development, but also timely payment of adequate 
salaries and allowances and a conducive work environment. 
Regular honest and supportive feedback on staff performance 
and activities are critical.
Field and district supervisors should keep track of the training 
received by staff under their supervision, and ensure that they 
are provided with regular opportunities for refresher training, 
ideally at least every three years. Specific new staff training 
mechanisms should be in place. Training should be evaluated 
for adequate retention of content among all staff.
At least every four years, national immunization programmes 
and their technical advisers should review and update the 
pre-service training curricula of vaccinators, health workers, 
programme managers, nurses and doctors, in order to ensure 
their ongoing relevance and accuracy. In addition, any major 
immunization policy change by the health authorities (e.g. a new 
scheduled vaccination) should be proactively communicated to 
professional and vocational health training institutions (e.g. 
nursing and medical colleges) to allow teaching materials to be 
updated continuously.
Every staff member at every level should be able to rely on regular 
supervisory interactions with their supervisor and a process for 
dialogue and feedback. The intent of these interactions should 
be clearly supportive, and while it may have some performance 
assessment components, its essence should be to reinforce good 
practices, to enable challenges and problems to be discussed 
and resolved, and to refresh training content. Supervisory visits 
and discussion points should be documented and reviewed at 
subsequent visits. While unscheduled supervisory visits may 
occasionally be appropriate, the staff member should have a 
clear and reliable indication of when the next supervisory visit 
can be expected. Supervisory visits should occur at least once 
a quarter based upon a review of past issues identified and 
solutions proposed and agreed upon.
National programmes should require regular training in 
supervisory methods and skills for all supervisors in addition 
to technical training. Conflict resolution, problem solving, adult 
learning and coaching, data interpretation and management 
should be included. Programmes should also use standard 
supervisory checklists to ensure appropriate procedure 
and follow-up, and a duplicate write-up of observations and 
recommendations should be left at health facilities.
Training can often be done individually through “eLearning” 
platforms, which may be through video, Internet and/or 
podcast: eLearning provides more flexibility for individuals to 
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should promote these learning methods by establishing 
learning progression tables and other incentives that motivate 
staff to use them. Where online facilities exist, they should be 
promoted; where they do not exist, stand-alone tablets, laptops 
or videos should be made available regularly for this purpose.
Adults learn best when they understand not only what they 
learn, but also why they are learning it. Their differing learning 
styles should be accommodated; an experiential, positive and 
encouraging learning process is needed. Ideally, learners should 
have opportunities to immediately put the training into practice 
to reinforce knowledge and practices. These principles should 
be reflected in all material directed at health workers.
Newly appointed and junior staff should be given access to a 
trusted and experienced staff member in their field to enable 
frequent, informal and open contact for mentoring support. 
Where it is not possible to have a mentor in the same 
location, regular “check-in” telephone conversations or visits 
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4.1.4. Ensuringvaccinequalityandavailabilityatalllevels








National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to ensure vaccine quality and availability.
TRANSFORMATIVEINVESTMENT
Invest in modernizing vaccine supply chains and management to ensure 
that the correct amounts of the right potent vaccines are available at each 
vaccination session
National immunization programmes and developmental 
partners should increasingly insist that valuable, costly and 
temperature-sensitive vaccines are handled by trained and well-
motivated professionals at national and subnational levels. It is 
a false economy to save on human resources in this area, which is 
critical to the success of the immunization programme. National 
and provincial logisticians should have achieved standard 
qualifications; prospective managers should be proactively 
trained. Academic, technical and professional logistics training 
qualifications such as LogiVac15 should be adopted as standard 
requirements for the appointment of logisticians.16
Immunization programmes are increasingly managing vaccines 
that are valuable both in monetary terms and in their impact 
on health. Many vaccines require storage and transport at 
cold chain (+2°C to +8°C) temperatures. The equipment needed 
to ensure this temperature consistency has to be fit-for-purpose 
and should be selected from WHO-tested and recommended 
equipment,17 maintained diligently, repaired rapidly when not 
functional and replaced at the end of its recommended period 
of use. Preventive maintenance (supplies, spares, staff time 
and travel) should be budgeted, and mechanisms put in place 
to notify the proper authorities immediately if equipment 
malfunctions so that rapid repair can be undertaken. Where 
necessary, funding for the cold chain should be ring-fenced to 
ensure that it is not used in other activities. All these functions 
should be included in immunization planning and budgeting, 
15  www.logivac.org
16   WHO/UNICEF. Immunization supply chain and logistics: a neglected but essential system for national immunization programmes:  
Call to action. WHO/IVB/14.05, July 2014. http://www.who.int/immunization/call-to-action_ipac-iscl.pdf
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reviewed for action regularly at all levels, and assessed in 
regular Effective Vaccine Management assessments (EVMs) and 
cold chain inventories.
In-country vaccine distribution systems need to be 
strengthened, as the findings from EVM assessments indicate 
that transportation systems are one of the weakest links in the 
supply chain. At lower levels, systems combine transportation 
of vaccines/supplies and health workers for service delivery; 
without reliable transport, the system starts breaking down. 
In some countries, private sector, civil society or other local 
partners may be used to contract services such as cold chain 
maintenance/repairs or transportation.
As higher temperatures rapidly spoil some vaccines, and the 
freezing of some vaccines renders them ineffective, all vaccine 
storage from the central cold store to peripheral vaccine 
carriers should have devices to monitor the temperature. In 
stores where large quantities of vaccines are kept, continuous 
electronic monitoring of temperature and an alarm system 
are indispensable, and should be insisted upon by programme 
managers and vaccine donors. At district and facility vaccine 
stores, continuous electronic temperature loggers should be 
standard equipment, and these should be recorded at least 
twice daily and any discrepancy remedied. In passive containers 
(cold boxes and vaccine carriers), appropriate temperature 
monitoring indicators (e.g. vaccine vial monitors, freeze 
indicators and other transport temperature indicators) should 
be used.
At all programme levels, but especially at national and 
first subnational level, vaccine forecasting and the timing 
of deliveries should be managed by a trained, competent 
logistician, taking into consideration current stocks, stocks at 
peripheral levels, seasonal variations and special activities such 
as campaigns and accelerated vaccination drives. Stock-outs 
represent a great danger to the programme and should be 
avoided where possible through astute management and the 
clear definition of minimum, maximum and order point levels at 
each store. The annual forecasting of vaccine needs should be 
jointly prepared with all in-country stakeholders, especially in 
countries relying on UNICEF procurement.
Data related to vaccine forecasting, supply and distribution 
should be available and reviewed at every level to facilitate proper 
vaccine management. Electronic spreadsheets and databases 
may facilitate the oversight, analysis and dissemination of data 
and should be promoted. Ideally, such data systems should 
provide visualization of stock levels and automatically alert the 
logistician to avoid low stock or stock-out situations. Visibility 
of working cold chain and stock available to the immunization 
programme at all levels, in particular at health facility level, 
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Several vaccines have now been licensed for storage at 
temperatures of up to 40°C for several days (the “controlled 
temperature chain” vaccines). Vaccine manufacturers should 
ensure that all vaccines are tested and licensed with the 
broadest possible temperature ranges, in order to provide 
logistic convenience at the furthest periphery by avoiding overly 
strict cold chain requirements. This feature enables further 
reach, higher coverage and less wastage of these vaccines when 
used in campaigns.
To maximize synergies and reduce transaction costs, vaccine and 
other medicine supply chains should be integrated safely where 
possible. Personnel managing such an integrated cold chain 
require expert training to avoid potentially harmful situations 
in which vaccines or their diluents may be confused with other 
medicines and distributed or injected erroneously, which can 
sometimes have fatal consequences. The vaccine supply chain 
may also be integrated with supply chains used by the public, 
private and civil society sectors.
Vaccine supply chain systems should be reviewed to optimize 
the number of steps in the chain and adapted to allow varying 
quantities and volumes of vaccines and all possible types of 
delivery strategies to be accommodated. The supply chain 
should be measured and managed for continuous quality 
improvement, including an accurate assessment of system 
costs and performance, and benchmarked against other, high 
performing supply systems.16 Similarly, the supply chain should 
be designed to ensure that vaccine diluents, injection materials, 
safety boxes, and reporting and stock management tools are 
distributed adequately and used appropriately. The role of 
“leapfrog” technologies, such as digitized stock management 
systems that allow ordering, dispatch notices, receipt notices, 
automated inventory updates on mobile phones or similar 
devices, should be explored.
Due to the increasing emphasis placed on the immunization 
supply chain by global partners, their activities and inputs 
should be coordinated globally and regionally. WHO, UNICEF and 
the Gavi Secretariat should lead a partnership group consisting 
of all interested stakeholders at global level and be given the 
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4.1.5.  Creating synergy among routine immunization,  
accelerated disease control efforts and new vaccine  
introduction activities
The GVAP activities and strategies below relate to creating synergy among routine 














National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to create synergy among routine immunization, disease 
control efforts and new vaccine introduction.
Large-scale vaccination campaigns have the ability to reach far 
beyond regular health services. Those using house-to-house 
vaccination or canvassing strategies offer an opportunity to 
review the vaccination status of all children encountered and to 
refer them for any needed doses. Additionally, through careful 
planning, campaign activities have the potential to strengthen 
routine immunization systems.18
Using methods developed in Cambodia19 and the Philippines, 
large-scale vaccination campaigns should be used to identify 
communities that are undervaccinated, not only for the vaccine 
being used within the campaign, but all scheduled vaccines; 
appropriate service delivery can subsequently be planned to 
reach these communities in a more sustainable manner. By 
reviewing campaign tally sheets, particularly for children under 
12 months of age, and triangulating them with routine coverage 
data, infants that should be receiving routine immunization 
services can be better targeted.
18   John Snow Inc. Using Measles Activities to Strengthen Immunization and Surveillance (UMASIS). 2011.  
http://www.jsi.com/JSIInternet/IntlHealth/project/display.cfm?ctid=na&cid=na&tid=40&id=8782
19   Sann Chan Soeung, John Grundy, Richard Duncan et al. From reaching every district to reaching every community:  
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Measles virus is extremely contagious and therefore seeks 
out and causes disease in undervaccinated or unvaccinated 
individuals. By using subnational data on the location of 
measles cases in addition to parameters such as low routine 
immunization coverage, areas of higher risk can be identified 
and appropriate remedial strategies designed.
During a vaccine-preventable disease outbreak, the first 
priority is to bring the disease under control. However, through 
increased public awareness created by an outbreak, there 
is an opportunity to identify programme weaknesses that 
failed to prevent the outbreak and correct them. As soon as an 
outbreak is suspected, enhanced social mobilization should be 
used to inform the affected community and additional routine 
vaccinations should be made available to all children of the 
appropriate target age group (based on disease epidemiology) 
presenting to a health facility or an outreach vaccination site.
As the maintenance and strengthening of the routine 
immunization programme is a key strategy in all vaccine-
related disease eradication or elimination programmes, the 
terms of reference of workers appointed in these eradication 
and elimination programmes should include routine system 
strengthening and coverage improvement activities. For this, 
polio- and/or measles-funded staff should receive regular 
training and updating on routine immunization skills. In 
countries where disease eradication or elimination personnel 
operate in parallel to the national routine immunization 
programme, it is essential to work towards the integration of 
these two programmes.20 Equally, the heightened attention 
provided by accelerated disease control initiatives should be 
used to raise political awareness, financing and ownership of 
the routine immunization programme as a whole.
To maintain the status of maternal and neonatal tetanus (MNT) 
elimination, countries should schedule and plan for the delivery 
of protective doses of tetanus toxoid-containing vaccines 
through routine immunization delivery platforms during 
childhood, adolescence and pregnancy periods; appropriate 
interventions should be chosen from the guidelines with 
consideration of what opportunities routinely exist for their 
delivery. Other interventions that prevent MNT such as hygienic 
practices during the birthing and neonatal period, cord care and 
trained birth attendants have to be maintained and expanded. 
Further, MNT elimination indicators should be regularly 
reviewed to remain vigilant. 
In countries with high enrolment of girls in primary school, 
school-based tetanus booster vaccination of girls and boys 
in the early grades before dropout can be considered. Taking 
advantage of the long duration of immunity through successive 
vaccine doses, this complementary strategy closes the immunity 
gap among boys and among adolescents of both sexes due to 
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waning immunity from infant doses and ensures that females 
routinely enter their most fertile reproductive years already 
protected against tetanus.
In line with the ambition to expand immunization programmes 
beyond the infant target group, countries that are considering 
the introduction of a routine measles second dose should 
establish this additional scheduled immunization visit as 
a broad “healthy child visit” in the second year of life. This 
opportunity should be used to provide other antigens, such 
as the DTP or polio booster or routine meningitis A vaccine, 
enabling previously missed doses in the national immunization 
schedule for infants to be given, and providing a platform for 
other preventive interventions such as deworming, vitamin A 
supplementation, nutritional advice and growth monitoring.
Both the interest of the population in a new vaccine and the 
increased communication effort during new vaccine introduction 
should be exploited to deliver broader immunization and 
coverage improvement messages, administer missed doses and 
provide additional prevention and disease control messages 
concerning newly targeted diseases. This should be emphasized 
with health staff and mobilizers during post-launch monitoring 
and post-introduction evaluations (PIEs) to ensure that new 
vaccines are integrated into the routine system. The strategic 
use of the introduction of a new vaccine to identify and address 
underlying chronic weaknesses in routine immunization 
enables the potential of the new vaccine to be realized.
Health worker training sessions on the administration of new 
vaccines and their disease- and vaccine-specific technical details 
are opportunities to refresh knowledge and skills on disease-
specific prevention and control of all other diseases targeted by 
routine vaccines.
New vaccine introductions require the adaptation of reporting 
forms, surveillance systems and training material, which 
should be used as an opportunity to reinforce the surveillance 
and monitoring of other vaccine-preventable diseases and 
programme activities where possible. In addition, AEFI 
monitoring and reporting may be enhanced during the period 
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4.1.6.  Integrating the routine immunization programme through 
comprehensive approaches and joint service delivery




National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to integrate routine immunization through comprehensive 
approaches and joint service delivery.
The use of newer vaccines, such as those for the prevention of 
hepatitis B, pneumococcal, rotavirus and human papillomavirus 
infection are vital interventions in the broader disease control 
efforts against chronic liver disease, acute respiratory infections, 
meningitis, severe diarrhoea and cervical cancer. Immunization 
with these vaccines should be part of comprehensive 
approaches and contribute to disease control goals. Other 
interventions, such as those to reduce alcohol and tobacco 
consumption, boost access to safe water and sanitation, oral 
rehydration, antibiotics and zinc supplementation, improved 
case management and appropriate antibiotic use, and provision 
of adolescent health interventions, should be reinforced during 
the introduction and routine delivery of these vaccines.21
Among all preventive health programmes and initiatives, the 
immunization programme traditionally has the greatest ability 
to reach infants, children and pregnant women, through “healthy 
child visits” and antenatal care. Through this programme, 
other interventions should be delivered at the same time to 
the appropriate age and target group where possible. The 
immunization programme has already been successfully used to 
deliver vitamin A supplementation, anti-helminthic treatment, 
insecticide-impregnated bednets and intermittent preventive 
treatment against malaria. Other important preventive 
interventions may be added, e.g. for adolescents. With all 
additions however, care should be taken not to overburden 
the immunization system to the extent of weakening it or 
compromising focus on its ability to reach its particular target 
age group(s). Where possible, a system for monitoring changes 
in quality of care (e.g. time per client), as well as acceptability to 
providers and clients, and any consequent decline in coverage, 
should be instituted. A system for identifying any unintended 
decline in equitable coverage, such as reduced vaccination of 
vulnerable groups, is also important.
The choice of intervention that is integrated will affect success, 
and needs some preparatory consultation and/or research to 
 
21   WHO/UNICEF. Ending Preventable Child Deaths from Pneumonia and Diarrhoea by 2025:  
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ensure that the additional services are truly high priority and a 
good match for the patterns of immunization services.
National immunization programmes should establish a system 
in which health services provided to women during pregnancy 
are recorded, including information on immunization 
services. Following birth, this process should ensure that new 
mothers and fathers are well informed about immunizations 
and newborns are tracked and followed up for appropriate 
vaccines. With the birth of the infant, birth registration and the 
distribution of a home-based record should be initiated (see 
“Include routine immunization in the health services at birth” 
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4.2. MANAGE the PROGRAMME 
4.2.1.  Securing all-level political commitment and partnership  
for routine immunization 

























National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to secure all-level political commitment and partnership.
The long-term sustainability of a vaccination programme 
can only be ensured when it is fully owned by the people it 
serves. National governments have a responsibility to deliver 
immunization services for the public good while working 
with donors and partners to ensure their compliance with 
programmatic leadership and priorities. External funding has 
to be coordinated and managed by the national government 
through its immunization programme in collaboration with 
partners in order to fill financial gaps. It is critical that external 
funding supports rather than redirects national priorities. 
Donor funds should be channelled through government and 
should be viewed as complementary and not as a replacement 
for government resources, and national governments 
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Under the leadership of the national ministry of health, 
immunization programme coordinating bodies, such as 
Interagency Coordinating Committees (ICCs), should be 
strengthened through the engagement of all immunization 
donors and partners operating in the country, including civil 
society organizations and professional bodies which often have 
more significant roles in countries where a large proportion of 
vaccinations are done through the private or nongovernmental 
sectors. Coordinating bodies may have a role to play in oversight 
of donor investment as well as ensuring cohesive immunization 
partner planning and activities. They may be tasked with 
activities beyond immunization and so may provide an 
opportunity to increase synergy with other programmes (such 
as maternal and child health); and they should be clearly aligned 
with health sector coordinating committees. The ICC should 
also clearly be synchronized and aligned with the health sector 
coordinating committee and the national health sector plan.
Immunization programmes have a compelling ability to 
demonstrate clear and tangible benefits with quantifiable 
costs, in particular in reaching equitable coverage. Accurate 
planning and costing in comprehensive multi-year plans (cMYPs) 
as well as the evidence of benefits in terms of preventing 
disease and death allow for strong advocacy with political and 
parliamentary decision-makers to ensure that political and 
financial commitment to the programme is strengthened. This 
may require country-specific cost-benefit and cost-effective 
analyses, perhaps drawing on WHO or other benchmarks, and 
using the more accurate data in the cMYP.
National programmes should ensure that legislation or a legal 
framework guarantees sustainable financing for immunization 
within the broader health systems financing, including 
provisions for a line item in the national budget for recurrent 
operational needs beyond vaccine and cold chain costs. In line 
with the GVAP indicators, government financing of the entire 
immunization programme should be monitored and reported 
globally. In all countries, vaccines and programme operations 
have to be seen as regular national budget items, and adequate 
budget allocation should be made according to financial 
requirements presented in the cMYP. Where these budget lines 
do not exist, immunization programme donors and partners 
should insist on their creation, to ensure national ownership.
Across the entire programme, transparency and accountability 
should be fostered and expected. This will entail the 
establishment or reinforcement of various committees 
and other coordinating mechanisms at all levels, with the 
involvement of key stakeholders, including communities, the 
private sector, donors, civil society organizations and the media. 
By introducing and strengthening peer review and performance 
review by stakeholders, including beneficiaries, increased 
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Nongovernmental organizations and civil society organizations 
should play a greater role in the promotion and delivery of 
immunization and strengthening of the health system, and 
representatives from stakeholder agencies and groups should 
be included and viewed as partners in programme planning and 
monitoring groups. This is especially valid in fragile or war-torn 
states. The independent voice of civil society may advocate 
effectively for the programme.
Since 2012, World Immunization Week has been celebrated 
annually in the last week of April, providing opportunities for 
social mobilization and advocacy. Countries should align their 
programme communications at this time to their region’s 
Immunization Week themes, and plan special events, such as 
mass vaccination campaigns, PIRIs, new vaccine introductions, 
and training sessions, workshops and roundtable discussions to 
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4.2.2.  Planning, budgeting and mobilizing resources for results 
and sustainability




















National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to plan, budget and mobilize resources. The emphasis in this 
section is on country-level planning and budgeting, which most often occurs through an 
immunization programme management team based in the national health authority. Where 
immunization programme management is decentralized to subnational structures, this 
section applies to the strengthening of planning and budgeting at that decentralized level.
TRANSFORMATIVEINVESTMENT
Invest in a coherent planning cycle, with strategic, comprehensive,  
multi-year and operational annual plans outlining and coordinating 
strategies and activities monitored quarterly
Through the development of a comprehensive, costed multi-
year plan,22 national programmes should articulate their overall 
programme direction and needs. Being comprehensive, they 
should contain all immunization-related activities, including 
increasing equity and coverage of Expanded Programme on 
Immunization (EPI) vaccines, control/elimination/eradication 
programmes for vaccine-preventable diseases, new vaccine 
introductions, mass vaccination campaigns, programme 
monitoring, and vaccine-preventable disease and AEFI 
surveillance over the five-year planning period. If costed 
appropriately, the cMYPs become a powerful tool to raise and 
allocate funding and to set priorities. At the same time, multi-
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year plans allow for ongoing long-term programme directions 
to be translated into implementable activities and annual 
planning. They have to align with other health ministry planning 
cycles and processes and should be informed by all relevant 
assessments and reviews, including EPI programme reviews, 
PIEs, surveillance and lab reviews, EVMs and data quality self-
assessments (DQS) etc.
The costing and impact information contained in the cMYP 
should be used to advocate for the programme’s importance and 
funding both for vaccines and for operational costs, especially 
within national governments and local authorities and among 
in-country partners. The accurate reflection of the activities 
planned and the gaps that exist to fund these activities allow 
for authoritative statements of resource needs. As domestic 
funding increasingly becomes a larger component of routine 
immunization financing, accurate and credible cost estimates 
will be essential. In countries that “graduate” from Gavi support, 
this emphasis on advocacy for domestic funding is critical.
The national annual operational plan of action22 should be 
promoted as the central and commanding document to guide 
the programme activities and to guide every partner’s input 
and aspiration to support in the country. In many countries, the 
annual planning process will include substantial components 
of subnational and district operational planning. All donor- 
and partner-promoted activities should find an entry in the 
operational annual plan of action; donors and partners should 
direct their funding to the existing financial gaps within these 
plans. It should also be understood that the cMYP and the 
national health sector planning activities should guide the 
annual operational workplan. As such, the annual plan has to be 
the functional and detailed expression of these broader multi-
year plans.
Detailed microplans for routine vaccination should serve as the 
basis for immunization services at district level, with inputs 
from health facility staff, as has been the case for accelerated 
disease control and eradication programmes, which are 
often separate. District and health facility microplans should 
be based on immunization programme analysis (coverage, 
achievements, gaps, etc.) from previous years, and consider 
the inputs by key community structures. They should contain 
descriptions of the communities served and the difficulties in 
accessing certain communities and groups (both physically and 
socially difficult to reach); fixed and outreach session planning 
in terms of frequency and routes; equipment and staff needs to 
accomplish the task; means of monitoring the achievement of 
these plans; and realistic costing and budgeting (including for 
operational costs).23
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Plans at all levels require a framework describing the monitoring 
of their progress and should state who is responsible for specific 
actions, the time by which the actions should be completed and 
how the completion of tasks should be measured and reported. 
Ideally, the means of ensuring accountability and responding to 
both positive and negative consequences should be described 
in broad terms. Systems for monitoring plan implementation 
and related expenditure should be strengthened. At national 
level, ICCs and other national bodies should be made aware of 
the progress made in implementing the plan at least quarterly. 
Similarly, at peripheral level, the coordinating structures such 
as ward health teams or clinic committees should be involved in 
the monitoring implementation of the microplans.
The immunization plans mentioned in the strategies above 
should be clearly linked and flow from each other. Thus, 
strategic, updated cMYPs should be the basis of an annual 
operational planning and budgeting process that results in 
annual plans of action. These should be monitored through ICCs 
and other national bodies at least quarterly. They should inform 
the updating of the next cMYP and annual plans and provide 
feedback to assist subnational levels in their planning.
To enable improved budgeting and resource allocation, 
methods of resource tracking should be established, at least 
down to the district level. Where activities have been curtailed 
or not implemented due to lack of funds, this should also be 
noted and reported. District-level health managers should 
analyse and report immunization (and other programme) 
efficiency measures, both in peer review settings and to the 
public (i.e. elected officials, civil society organizations and other 
subnational stakeholders). District health managers could 
also strengthen involvement of their accountants in resource 
tracking of health activities, including spot-checking planned 
versus conducted activities.
TRANSFORMATIVEINVESTMENT
Invest in ensuring that sufficient and adequately appropriated funds reach 
the operational level of the programme regularly.
At least annually at global level, the financing trends of national 
immunization programmes and donor funding flows to 
immunization as a whole should be analysed and made available 
broadly. These should contain analyses of governmental funding 
commitments to immunization, a summary of the financial 
status of immunization globally and analyses of financial 
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4.2.3.  Ensuring excellence in national programme leadership  
and management





National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to ensure excellence in leadership and management. The 
emphasis in this section is on senior country-level leadership, which most often occurs 
through an immunization programme management team based in the national health 
authority. Where immunization programme management is decentralized to subnational 
structures, this section applies to the strengthening of planning and budgeting at that 
decentralized level.
TRANSFORMATIVEINVESTMENT
Invest in a capable national team – supplied with sufficient resources and 
authority – to expertly manage each country’s national immunization programme.
The technical, managerial and budgeting capacity and 
authority of the national immunization management team 
is a key factor in the success of its programme. Governments 
and their development partners should strengthen the senior 
management team through systematic capacity building and 
performance improvement approaches. Both the recruitment of 
individuals to this team and its functioning should emphasize 
good management and leadership aptitude and skills. Key 
training topics must include management and supervisory skills, 
leadership capabilities and technical updates. In line with WHO’s 
mandate to develop health norms and standards, an outline 
of staffing needs and managerial competencies and model 
job descriptions should be developed as guidance to national 
decision-makers in staffing their national programme teams.
At national level, a full understanding of the financial situation 
of the programme is needed to enable the prioritization 
of activities most critical to success. Ideally, the national 
programme manager should have the skills needed to 
undertake financial analysis, interpretation and management, 
and to communicate and present financial data, including for 
advocacy. Larger national teams would benefit from having a 
financial administrator to track resources and create reports. 
At the subnational level, especially in decentralized settings, 
managers responsible for implementing immunization 
strategies and activities should have the skills needed to 
assess financial and other resource flow issues that constrain 
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International health agencies such as WHO and UNICEF should 
develop the means to allow senior national programme 
managers to work for short periods alongside their peers in 
other countries (e.g. during EPI programme reviews or during 
measles SIAs planning and monitoring), thereby allowing for the 
synergistic strengthening of both parties.
EPI managers meetings are a vital means of enhancing 
intercountry learning and support that allow for networking 
and establishment of closer relationships between managers 
of countries in similar circumstances. Development partners 
and governments should ensure that key national leaders in 
the immunization programme attend these meetings and that 
they operate as an open and consultative forum for the sharing 
of experiences and mutual learning. The establishment of the 
International Association of Immunization Managers provides 
another venue for exchanges of experiences of this cadre. Online 
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4.2.4. Setting programme policy and guidance





































National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to set programme policy and guidance.
National programmes should be encouraged to review 
policy using their local expertise and experience. Global 
recommendations are important to drive progress through a 
framework that countries can adapt to local epidemiologic, 
economic and other circumstances in the context of their other 
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and other technical bodies should be reviewed and adopted 
where appropriate, and local modifications to WHO and other 
normative policy recommendations should be made on the 
basis of country-based evidence and experience. National 
health authorities should convene the appropriate experts and 
take into account their recommendations.
In many countries, national immunization policy is set with 
the help of NITAGs that aim to guide its formulation and 
develop strategies to advise decision-makers and programme 
managers on technical issues, including recommendations 
on vaccine introduction and immunization schedules. Their 
recommendations should be evidence-based and generated 
through transparent processes. Members are usually 
appointed by the health authorities based on their technical 
expertise and experience and their ability provide valid 
recommendations on policy changes. NITAGs should engage 
with academia, professional societies and other national 
agencies and committees to ensure a cohesive and coordinated 
approach to achieving national health priorities. They should 
be strengthened structurally through regular meetings, 
independent membership and proper management of conflicts 
of interest. NITAGs should also be strengthened through capacity 
building of their members and provision of increased quality of 
evidence on which their recommendations are based. NITAGs 
are technical advisory bodies with a purpose distinct from ICCs 
(partner coordinating bodies that support implementation of 
national programmes).
In all cases, policy recommendations should be based on best 
evidence and data through a process that is led in-country. 
Where these data, such as on the disease burden, do not exist in a 
country, information and experiences from other countries may 
be used. In addition, specific research projects may be initiated 
to answer policy questions in a country-specific manner.
More than 100 developing countries rely on the WHO vaccine 
prequalification process, which allows United Nations agencies 
(e.g. UNICEF) to procure assured-quality vaccines for them. 
Countries producing and/or procuring their own vaccines 
should rely on their own regulatory system or a functional third-
party country. National regulatory authorities should build their 
capacity and sustain WHO-recommended regulatory functions 
to ensure quality, safety and efficacy, product labelling and 
immunization programmatic needs for all vaccines they use.
Various technical, regulatory and advisory bodies (e.g. NITAGs, 
NRAs, technical subcommittees of ICCs) should coexist and 
cooperate in a well-functioning immunization programme. The 
national authorities should ensure these bodies operate in close 
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Immunization programme managers at all levels should 
encourage the collection and dissemination of good practices 
as identified by local immunization managers and vaccinators 
to address practical needs. This requires managers to reassure 
staff that suggestions for improvement are welcome; managers 
should in turn disseminate and provide incentives for good 
practices in their teams. National programmes should seek 
nursing and medical teaching institute support for devising 
better immunization service delivery.
Global and regional advisory committees and policy-making 
bodies such as the SAGE, the Immunization Practices 
Advisory Committee (IPAC), the Immunization and Vaccines 
Implementation Research Advisory Committee (IVIRAC) and 
the Regional Immunization Technical Advisory Groups (RITAGs) 
should review new developments in vaccines and immunization 
practices and make global and regional recommendations. 
These are routinely published and should be made available 
to programme managers and NITAGs regularly and in a timely 
manner that enables sufficient flexibility for development of 
in-country policy and technical discussions for decision-making.
Bringing together programme managers, technical agencies, 
civil society and global partners in the annual EPI managers 
meetings creates a valuable opportunity for networking and 
allows for country peer-to-peer sharing of experiences. It is 
essential that programme managers attend and participate 
actively in these meetings both to be updated on global and 
regional policy changes and implementation and to share their 
practical experiences and pragmatic approaches with others.
Programmatic needs should be taken into consideration in the 
development of vaccines and their presentation and packaging. 
The formal prequalification of vaccines entails consideration 
of the programmatic suitability of candidate vaccines;25 those 
that meet programmatic needs and preferences are favoured. 
At global level the Vaccine Presentation and Packaging Advisory 
Group (VPPAG) serves as a collaborative forum between vaccine 
manufacturers and partner agencies on these matters globally.26
25   WHO. Assessing the programmatic suitability of vaccine candidates for WHO prequalification PSPQ (Revision 2014).  
January 2015. WHO/IVB/14.10
26   WHO. Immunization in Practice - A practical guide for health staff. Geneva: World Health Organization; 2015. 
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4.3. MOBILIZE PEOPLE
4.3.1. Engaging communities and creating demand for vaccination














National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to engage communities and create demand.
Immunization services at local and district levels should 
regularly meet traditional leaders as well as other influential 
individuals and civil society organizations in their community 
to provide updates on immunization coverage and disease 
and AEFI occurrence and maintain interest in immunization; 
community members should be involved in programme planning 
and monitoring. Where feasible, health staff should provide 
an orientation for community leaders (traditional, religious, 
educational and civic leaders and volunteers) on immunization 
and prepare them to respond effectively to families’ questions 
and concerns. Mechanisms should be established for 
community members to give feedback and suggestions on 
vaccination services. Community members should also be 
active participants in health/immunization committees. When 
outbreaks of vaccine-preventable diseases occur or when parts 
of the community have concerns or criticisms of immunization 
services, the facilitation of community leaders and civil society 
organizations should be sought in responding to these concerns 
or criticisms. Civil society organizations can often play a role in 
helping to develop these relationships.27
TRANSFORMATIVEINVESTMENT
Invest in the shared responsibility for immunization delivery between 
communities and the immunization programme to reach uniformly high 
coverage through high demand and quality services.
27   “My home, my village” in Immunization Handbook for Medical Officers published by Department of Health and Family Welfare,  
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Representatives of each community should be engaged in 
immunization programmes for mobilizing eligible populations, 
disseminating information and discussing concerns with health 
staff. Equally, quality issues such as schedule compliance, 
vaccine handling, safety, and engagement and communication 
with the community should be discussed. A focus on educating 
health committees in all aspects of quality service may help 
increase community demand for quality, and community 
willingness to support investment in the infrastructure and 
systems required for a good-quality service. Health staff should 
enable community volunteers to keep a register of children 
and women to track immunization status and promote a fully 
immunized and healthy community. A small group of community 
leaders and representatives should be invited to meet regularly 
with the management of health facilities to discuss issues of 
common concern, specific community needs and to plan for 
special events. The community should be encouraged to take 
pride in “their” clinic; they may volunteer services in maintaining 
the health facility in good repair. Similarly, volunteer community 
mobilizers and defaulter tracers should be encouraged to 
become part of the extended health team.
In forums such as school meetings, community events and 
health days, health facility staff should be encouraged to 
allocate time to provide educational talks or inputs on the 
immunization programme and other preventive health topics. 
During clinic sessions, a health worker or a volunteer should be 
designated to provide structured health talks on various themes 
to waiting clients.
Both at national and local levels, immunization information 
materials should be produced and updated to be made available 
to schools and other educational institutions. These materials 
should be up to date and adapted to the audience; teachers 
using these materials should be trained. Materials should 
be easy to read, free from technical jargon and written in the 
appropriate language.
Very basic messages and information on immunization should 
be developed to allow child-to-child promotion of vaccination. 
Children can also remind their parents when future doses for 
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4.3.2. Mobilizing and communicating for vaccination28





















National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to mobilize communities and individuals, and communicate 
information about the benefits of immunization.
Communication and advocacy should be planned, budgeted 
and implemented through cMYPs and annual plans of action. 
Communication and advocacy experts should be consulted in 
designing these strategies.
Each country should have an immunization communication 
strategy concerning routine immunization and the benefit 
of vaccines in its national and local languages, which is 
adapted to local cultures. The strategy should be prepared and 
disseminated for print, broadcast and electronic distribution 
with the input and guidance of communities, the media, civil 
society and other stakeholders.
The trust people place in advice from health care professionals 
is well recognized and influential. It is therefore essential that 
health care professionals, especially primary care and family 
doctors, paediatricians and child health specialists, reinforce 
the benefits of immunization through clear, unbiased messages. 
Professional associations should be advisers/partners for the 
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immunization programme and its coordinating bodies. They 
should make unequivocal statements on the need for and 
benefits of vaccination and participate in reinforcing them 
during special events such as World Immunization Week, “child 
health days” and launches of new vaccines.
In this era of social connectivity, immunization programmes and 
development partners should build capacity among programme 
communications and managerial staff on use of these 
semi-individual marketing channels to expand reach, foster 
engagement and increase access to credible, science-based 
health information. In addition, programmes should capitalize 
on text messaging to send immunization visit reminders 
to caregivers and to follow up on missed vaccinations. Text 
messaging can be used to remind village volunteers which 
children in the village are due or overdue for vaccines.
Locally, nationally and at the global level, celebrities should be 
sought out to act as advocates and “goodwill ambassadors” 
for immunization. The choice of celebrities should be based 
on their ability to promote the public health aspect of 
immunization and their appeal to targeted segments of the 
population used to the programme’s advantage. Community and 
religious leaders should be actively engaged in immunization 
programme advocacy and communications. High-level positive 
pronouncements and approval of immunization and vaccines 
should be sought from global, established religious bodies 
and organizations.
Where electronic communication is difficult, basic, low-
technology health education materials such as infographics 
and laminated educational flip charts should be designed for 
use in health education sessions at fixed facilities and during 
outreach sessions. These materials should be seen as a stimulus 
to discussion and questions, not top-down communication. 
Where appropriate, media such as short health educational 
films and info-spots should be used to provide messages to 
waiting clients. Messages should focus on easy-to-remember 
and picture-rich messages relating to immunization issues. 
Quality interpersonal communication by facility immunization 
staff should be emphasized, using key messages that are also 
tailored to clients’ informational and scheduling needs.
Community mobilizers are essential for the provision of 
information and reassurance to parents and caregivers in the 
community. The direct “word-of-mouth” method of promotion 
by a known and trusted individual can help ensure a favourable 
view of immunization. Thus, districts should assure that 
community mobilizers are adequately prepared through 
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4.3.3.  Addressing vaccine hesitancy, false perceptions and 
the negative consequences of adverse events following 
immunization











National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to address vaccine hesitancy, false perceptions and negative 
consequences of AEFIs.
While increasing client participation in health care decisions 
is a welcome development, health care professionals should 
have the skills to communicate on the success and positive 
impact of vaccination, to advise on the unmistakable benefits 
of immunizations, and to counsel and manage vaccine-hesitant 
caregivers so that they may make balanced, evidence-informed 
decisions.29 It is therefore necessary for health workers 
themselves to be knowledgeable about and communicate 
effectively both the risks and the benefits of vaccination.
Reasons for vaccine hesitancy or refusal can be very different 
from reasons relating to quality and friendliness of services. 
National programmes, along with their districts, should 
recognize and develop specific interventions to address the 
context-specific reasons for non-vaccination. Poor quality 
primary and local health services breed a mistrust of all health 
services, including immunization. Child health services should 
be improved to be more acceptable to caregivers such that they 
have the confidence and trust needed to bring their children in 
for all essential health services, including immunization. Equally, 
other non-financial barriers to access, such as those arising from 
gender, ethnicity, religion, and other socioeconomic factors, 
need to be identified and rectified. Where population segments 
advocate vaccine hesitancy or refusal, or consider local services 
to be inappropriate for their needs, national programmes and 
civil society should use behavioural science methods to identify 
the key concerns of these populations and design specific 
interventions to address them.29
29   WHO/EURO. The Guide to Tailoring Immunization Programmes (TIP):  



























































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
AEFIs are observed in immunization programmes for a variety 
of reasons and many are temporally and coincidentally (as 
opposed to causally) related to vaccination. AEFIs are often 
not caused by the vaccine or the immunization process and 
are incidental. In some cases, serious AEFIs may be caused 
by a vaccine’s intrinsic constituents, an individual’s reaction 
to the vaccine, an immunization-related error caused by 
inappropriate vaccine handling, prescribing or administration, 
or as a result of recipient’s anxiety around immunization. In 
any case, coincidental, vaccine- or vaccination-related events 
or programmatic errors may harm the programme if not 
well handled. National immunization programmes should 
establish, distribute and promote the use of standard operating 
procedures for handling AEFIs and for assessing causality. 
Health care workers should be empowered to report AEFIs 
without fear of repercussions or reprisals.
National programmes should allow for and train a national 
AEFI committee that can review all reported serious adverse 
events, including at short notice if required. Such a committee 
can advise on further investigation to establish causality, 
reach conclusions and make authoritative recommendations 
to the national immunization programme and regulatory 
authorities. They can also provide independent oversight on 
the development of the national AEFI monitoring system. AEFI 
review committees should include both technical experts and 
communicators and be independent of health care authorities 
to avoid conflicts of interest. Guidance and recommendation 
provided by the Global Advisory Committee on Vaccine Safety 



























































CHAPTER 4COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
4.4. MONITOR PROGRESS
4.4.1.  Monitoring programme performance and disease occurrence


















National immunization programmes, supported by all partners, should pursue the following 
GRISP strategies and activities to monitor programme performance and progress and 
measure disease reduction within the context of broader health programme and disease 
surveillance activities.
TRANSFORMATIVEINVESTMENT
Invest in an information system that identifies and tracks each person’s 
vaccination status.
At all levels, a strong culture of using data as the basis for 
making programme decisions should be fostered. Programme 
staff and managers at all levels should have basic skills and 
understanding of how to record, review and interpret data, and 
how to draw valid conclusions from them. These competencies 
should be regularly taught and supervised. Opportunities for 
sharing and discussing data, such as peer-to-peer exchange and 
review meetings should also be used as means of improving 
decision-making at all levels and ensuring feedback and feed-in 
dialogue and loops. Information regarding vaccine coverage 
and VPD surveillance should be shared with NITAGs at least 
twice a year to identify any areas needing further engagement 
and improvement.
Programmes should review and facilitate accurate and timely 
coverage reporting from the point of vaccination and the 




















































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
record, along the path of data aggregation and summarization, 
to the calculation of coverage rates at district, provincial and 
national levels. As data increasingly become the main driver of 
programme direction, their quality has to progressively improve 
along with staff ability to compare, analyse, triangulate and act 
on them. This improvement relies on the ongoing review of the 
gathered data, feedback to those reporting and evaluating and 
questioning the interpretation resulting from these data.
Target population estimates and denominators for coverage 
measurements are often difficult for national and district 
managers to assess, resulting in vaccine forecasting and 
supply errors, difficulties in activity planning and inaccurate 
coverage rates (e.g. coverages being reported as over 100%). It 
is of paramount importance that immunization programmes 
develop progressively better information on target populations 
in conjunction with national statistics offices, if national 
demographic information is sound. If not, they may consider 
other methods of local target population estimation and 
comparison, such as trend analysis or collaboration with other 
authorities (e.g. those responsible for electoral rolls or school 
enrolment). Where the vital registration system is strong, 
national or subnational data from birth registrations should be 
considered. Conducting local headcounts of all children under 
five years of age, registering all home deliveries by village, or using 
volunteer health workers and community-based organizations 
in some settings are all ways to obtain more accurate target 
population figures, resulting in more realistic estimates of 
coverage. They also help in identifying and tracking defaulters.
At each level that records, aggregates, summarizes, interprets or 
transmits data, these processes should be made easier through 
proper form and process design and clear instructions and 
guidance on data aggregation and transmission. Where data 
are regularly received from a more peripheral level, feedback 
from the higher level back to the periphery is important to 
provide accountability and motivation. Systematic, accurate 
and timely feedback to data users, with opportunities for 
review, monitoring, and analysis, is a mainstay of data quality 
improvement. At all levels, the availability of updated reporting 
forms should be ensured and data providers properly trained. 
For both paper and electronic data collection and transmission 
systems, archiving instructions should be clear. All required 
parties should be included in the reporting scheme to avoid 
miscommunication even when using electronic systems.
Facility immunization registers (book-based or patient-card-
based) should be designed to accommodate the need for 
effective follow-up and oversight regarding which doses are 
required. Registers should be kept according to the birth month 
of the child, and each child should be entered once and uniquely 
identified to ensure efficiency, and a sequential number 
allocated for ease of backtracking. Where appropriate, contact 
details of the caregivers, including mobile phone numbers, 
























































CHAPTER 4COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
In developing country settings, a paper-based register is the 
basic requirement in all vaccination sessions; as facilities 
become electronically enabled, the facility registers may be 
transformed into electronic databases. Data generated from 
outreach activities sometimes either gets omitted or duplicated; 
therefore, where outreach teams come from the district, it is 
important that data should be left at the respective health 
facilities in those catchment areas.
With the expansion of mobile networks and communications 
such as text messages and smartphone apps, national 
programmes should explore the feasibility of using such 
technology for coverage and activity monitoring and feedback, 
including appointment reminders, defaulter tracking and the 
establishment of electronic registries (ideally linked to the birth 
registry). Vaccine supply and forecasting data could be added 
to these processes. Electronic data collection allows useful 
analysis and enables closer programme monitoring (e.g. local 
coverage surveys) and better responsiveness at all levels.
Polio and suspected measles and rubella case-based surveillance 
form the backbone of VPD case surveillance and are an 
absolute requirement in disease eradication and elimination 
programmes. On this basic surveillance infrastructure, other VPD 
case reporting should be established, improved or maintained, 
including MNT, diphtheria, pertussis and congenital rubella 
surveillance. As the reporting of AEFIs follow the same basic 
structure as case-based surveillance, AEFI reporting should be 
integrated in overall case reporting systems.
The global polio, and measles rubella laboratory networks 
have established an excellent record of providing rapid 
confirmation of case-based suspected disease occurrences. 
This existing network infrastructure and expertise should be 
expanded where appropriate to provide confirmation services 
for other vaccine-preventable diseases including yellow fever, 
Japanese encephalitis and hepatitis B. Routine serological and 
polymerase chain reaction (PCR) confirmation of cases can 
further be enhanced in selected cases by molecular testing and 
characterization of the virus. These laboratories should become 
part of a larger diagnostic service that extends to non-vaccine-
preventable diseases such as HIV. Accredited regional reference 
laboratories should be established to oversee the quality and 
accuracy of diagnostics in peripheral laboratories.
For several new vaccines, programme impact is mainly measured 
through a laboratory-based sentinel hospital surveillance 
system. In some countries, surveillance is based on a fixed 
catchment population, allowing for disease incidence to be 
followed; in most others, sentinel surveillance provides general 
disease information. Currently, invasive bacterial disease 
(IBD) sentinel surveillance is being put in place to monitor 
bacterial meningitis and, in some countries, bacterial causes 































































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
also in place. Every country introducing a new vaccine into the 
immunization programme should consider establishing sentinel 
hospital surveillance to provide data for decisions on vaccine 
introduction and use. This platform may be further enhanced 
for surveillance of other vaccine-preventable diseases, e.g. 
congenital rubella syndrome or typhoid fever. Surveillance 
programmes should in turn be evaluated through surveys, 
assessments and reviews.
4.4.2.  Evaluate the programme through surveys, assessments  
and reviews




National immunization programmes, supported by all partners, should pursue the following 
listed GRISP strategies and activities to evaluate their programme.
A comprehensive review covering all levels, conducted by the 
national immunization programme, and involving staff and 
external participants, provides a snapshot of the strengths and 
weaknesses of the immunization and broader health system 
and provides additional external recommendations on possible 
remedies to challenges and shortcomings. Such programme 
reviews should be a core component of the situational analysis 
of the cMYP, and should equally feed into health sector plans. 
The recommendations made in the programme review should 
result in clearly outlined improvement activities and must 
find entry into the national operational planning processes. 
As cMYPs should be undertaken every three to five years, 
programme reviews should be conducted prior to each cMYP. 
Progress made in implementation of the recommendations from 
the programme reviews and assessments should be formally 
included in the process of reviewing and updating the cMYPs.
The introduction of a new vaccine is a major immunization 
system event, which should be evaluated within 12 months. PIEs 
and the national immunization programme reviews mentioned 
above may be conducted simultaneously by adding a PIE module 
of questions to the programme review. Recommendations from 
PIEs should be taken up in the updated cMYPs and annual plans 
of action (see above), and should also be reviewed prior to the 
introduction of a future vaccine.
Periodic coverage surveys should be conducted in countries to 
validate administrative data and collect additional information 
on unvaccinated and undervaccinated populations. Coverage 
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85% and where population data is questionable. Social and 
economic determinants that affect coverage, which are 
important for addressing barrier issues and improving equity, 
should be added as appropriate. Coverage validation is especially 
important in countries where administrative coverage data 
are incomplete or uncertain or where issues exist with target 
population data; regular immunization coverage surveys should 
be conducted to substantiate administrative coverage. These 
surveys should be carefully designed to balance the resolution 
and accuracy of the survey with its cost and effort. Field data 
collection should be closely monitored; data analysis and 
interpretation should be verified. With the growing number of 
vaccinations in the immunization schedule, a caregiver’s recall 
may be less reliable and additional effort should be made to 
harmonize and review home- or facility-based records. Coverage 
surveys should also contain information about the availability 
of home-based records, coverage of the “fully immunized child” 
and reasons for being undervaccinated when missed doses 
are noted.
The EVM allows a country to analyse the weaknesses and 
strengths of its vaccine supply chain from central level to the 
lowest delivery level and develop an improvement plan based 
on its findings. Nine key components30 of the supply chain 
are evaluated at national, subnational and district levels. The 
improvement plan should then be a “living” document that is 
actively used to make programme changes and advocate for 
additional resources as needed.31
National programmes and in-country partners should 
adopt the three-step approach of assessing, planning and 
implementing change within the national immunization 
programme budgeting, planning and financing cycle. This 
three-step approach to EVM should address current and future 
supply chain challenges, especially those linked to new vaccine 
introduction. Countries should make every effort to achieve 
an effective vaccine management system that meets the 
minimum recommended standard for each criterion and each 
level of the in-country supply chain. Once implemented, the 
immunization supply chain should be optimized, continually 
adapted and monitored to its changing context with innovative 
approaches and technologies. Countries should commit the 
necessary human and financial resources to address existing 
and anticipated challenges of immunization supply chain and 
logistics systems.
30   The nine global EVM criteria are: (1) pre-shipment and arrival procedures ensure that every shipment from the vaccine manufacturer reaches 
the receiving store in satisfactory condition and with correct paperwork; (2) all vaccines and diluents are stored and distributed within 
WHO-recommended temperature ranges; (3) cold storage, dry storage and transport capacity is sufficient to accommodate all vaccines and 
supplies needed for the programme; (4) buildings, cold chain equipment and transport systems enable the vaccine and consumables supply 
chain to function effectively; (5) maintenance of buildings, cold chain equipment and vehicles is satisfactory; (6) stock management systems 
and procedures are effective; (7) distribution between each level in the supply chain is effective; (8) appropriate vaccine management 






















































CHAPTER 4 COMPREHENSIVE FRAMEWORK OF STRATEGIES AND PRACTICES FOR ROUTINE IMMUNIZATION
Several methodologies exist to identify programme challenges 
in communities; national programmes should apply these where 
routine immunization coverage is low or underperforming. 
These include linked household and facility surveys, KAP 
assessments and “Hundred Household” Assessments.
The reliability and accuracy of the reporting system as data 
is reported from one level to the next higher level should 
be assessed every 2–3 years using the DQS or other in-depth 
reviews (e.g. iDQA), annual desk reviews of data using standards 
indicators in systems where reporting flaws are expected.32 
In all countries, data should be digitalized at least at national 
level through a system that is stand-alone or part of the 
national health information system; this system should also be 
regularly assessed.
The disease reduction impact becomes evident only decades 
after the start of hepatitis B vaccination, as chronic liver disease 
develops only later in life. To measure the impact of vaccination 
earlier, and to document progress in regions with hepatitis 
B control goals, representative serosurveys are necessary. In 
addition, in some settings, serosurveys may be informative 
in measles and rubella control as well as MNTE to illuminate 
susceptibility gaps in the population.

















































































































































CHAPTER 5 MEASURING GRISP PROGRESS THROUGH THE GVAP
5. MEASURING GRISP PROGRESS 
THROUGH THE GVAP
The GVAP outlines a Monitoring and Evaluation Accountability Framework to measure progress 
towards its goals and it acknowledges this tracking to be a critically important element of the GVAP. 
Recognizing the importance of closely monitoring progress in implementation of the GVAP, the 
World Health Assembly (WHA), in resolution WHA65.17, called for annual reports on progress to be 
submitted to each Regional Committee meeting and to the WHA, through the WHO Executive Board.
 
GRISP aims to describe the routine immunization strategies directly related to GVAP, and no 
new milestones and indicators are articulated for this document. The goal and the indicators 
pertaining to routine immunization system strengthening and coverage improvement in the GVAP 
are reiterated here.
The progress of routine immunization systems strengthening and coverage improvement will be 
discernible through the monitoring of all GVAP goals, but the following goal and strategic objectives 
are highlighted as being especially associated with the strategies and practices outlined in GRISP.
33 WHO/UNICEF Joint Reporting Form
Process of monitoring GVAP progress through  
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Reach 90% national coverage  
and 80% in every district  
or equivalent administrative unit  
with three doses  






To be reached by  
all Member States  
by end 2015
3.2
Reach 90% national coverage  
and 80% in every district  
or equivalent administrative unit  
for all vaccines  
in national programmes,  
unless otherwise recommended
To be reached by  
all Member States  
by end 2020









Domestic expenditures  





Increasing trend in-country  
funding allocation to national  
immunization programmes
1.2
Presence of an independent  
technical advisory group  
that meets defined criteria 











Percentage of countries that  
have assessed (or measured)  
the level of confidence  






Increasing trend in the %  
of countries having assessed  
the level of confidence  
in vaccination at subnational level
2.2
Percentage of un- and undervaccinated 
in whom lack of confidence  
was a factor that influenced  
their decision
Decreasing trend in the distribution  
of % of un- and undervaccinated  
in whom lack of confidence is a factor  










Percentage of districts  
with 80% or greater coverage  







All countries with all districts  
≥80% DTPc3 coverage by 2020
3.2
Reduction in coverage gaps  
between wealth quintiles  
and other appropriate equity  
indicator(s)
Increasing trend in equity  
in immunization coverage;  
Proposed target to align  
with Gavi targets: proportion  
of countries with < 20% difference  
in coverage between 
 wealth quintiles 60%  























































4.1. Dropout rate between  







Decreasing trend  
in dropout rate
4.2
Sustained coverage of  
diphtheria-tetanus-pertussis-containing 
vaccines 90% or greater for three  
or more years
All countries  
by 2020
4.3
Immunization coverage  
data assessed as high quality  
by WHO and UNICEF
All countries to have  
high-quality immunization  
coverage data by 2020
4.4
Number of countries  
with case-based surveillance  
for vaccine-preventable diseases
 100% of countries for polio and  
measles surveillance by 2015
 75% of low- and middle-income  
countries for sentinel  




Percentage of doses  
of vaccine used worldwide  
that are of assured quality











Progress towards development  





Proof of concept for a vaccine that shows 
greater or equal to 75% efficacy  
for either HIV/AIDS,  
tuberculosis, or malaria 
6.2
Progress towards a universal  
influenza vaccine  
(protecting against drift  
and shift variants)
At least one vaccine providing  
broad spectrum protection  
against influenza A virus licensed
6.3
Progress towards institutional  
and technical capacity  
to carry out vaccine clinical trials
Every region has a solid base  
of countries competent in hosting  
and managing vaccine trials
6.4
Number of vaccines that have  
either been re-licensed or licensed  
for use in a controlled temperature 
chain at temperatures above  
the traditional 2–8°C range
Increasing number  
of vaccines
6.5
Number of vaccine delivery technologies 
(devices and equipment) that have 
received WHO prequalification against 
the 2010 baseline
Increasing number  
of technologies
With the endorsement of the GVAP at the WHA in 2012, the monitoring and evaluation/accountability 
framework came into force, and countries report progress against the GVAP indicators annually. 
Progress is monitored by the SAGE Working Group on the Decade of Vaccines, which also provides 











































































































To reach the routine immunization goals outlined in the GVAP, GRISP formulates nine transformative 
investments in routine immunization that will make a difference in the coming years if implemented. 
These areas should be seen as a call to action and investment by all parties involved in improving 
routine immunization coverage and immunization systems strengthening – governments, donors 
and partners. 
Using the comprehensive framework of strategies and practices outlined in GRISP, creative, locally 
adapted methods of improving the routine immunization system should be devised by national 
immunization programmes. Partners and donors should consider this framework in formulating 
their own strategic direction and planning. 
As the Decade of Vaccines nears its mid-point, there is an urgent need to reassert routine 
immunization as the foundation for sustained decreases in morbidity and mortality from vaccine-
preventable diseases across the life-cycle of all individuals. Immunization programmes flourish only 
where they are supported and embedded in the functioning of the broader national health system, 














































ANNEX A: Role of stakeholders in routine immunization
National and subnational governments
Immunization programmes are entities that operate within national health ministries, 
and are owned by the governments of sovereign States. Governments are accountable 
to their own people for the delivery of all health services and programmes, including the 
immunization programme.
The central roles of national and subnational governments in the immunization 
programme are:
◆◆ accountability for the programme delivery and results;
◆◆ programme leadership and oversight;
◆◆ national policy setting and guidance;
◆◆  responsibility for resources management for vaccines and the operational cost of 
the programme;
◆◆ responsibility for the supply of adequate, quality-assured vaccines;
◆◆ quality assurance of the vaccines used as well as the quality of vaccination services;
◆◆ community and client trust-building and responsiveness to hesitancy and concerns;
◆◆  programme monitoring and disease surveillance through the collection, reporting and 
feedback of appropriate high-quality data;
◆◆  coordination and stewardship of partners and donors providing support for routine 
immunization, including assistance with in-country capacity building and performance 
improvement to strengthen and sustain country ownership.
World Health Organization
WHO has been mandated by its Member States to provide technical leadership in health and 
immunization in support of national governments and programmes. The Organization should 
be seen as the collective voice of its Member States on health matters. In its Constitution, 
Member States formulated the objective of WHO as “the attainment by all peoples of the 
highest possible level of health”.34 Contributing to this objective, several functions of WHO 
are identified in the Constitution, including:
◆◆ to act as the directingandcoordinatingauthority on internationalhealthwork;
◆◆  to establishandmaintaineffectivecollaboration with the United Nations, specialized 
agencies, governmental health administrations, professional groups and such other 
organizations as may be deemed appropriate;
◆◆ to assistGovernments, upon request, in strengtheninghealthservices;
◆◆  to furnishappropriatetechnicalassistance and, in emergencies, necessary aid upon the 
request or acceptance of governments;
◆◆  to establish and maintain such administrative and technical services as may be required, 
including epidemiologicalandstatisticalservices;
◆◆ to stimulateandadvanceworktoeradicateepidemic,endemicandotherdiseases;
◆◆ to promote maternalandchildhealthandwelfare.
In addition to these functions, WHO’s current broad directions include the pursuit of 
universal health coverage and the IHP+, which provide the overarching context for its role in 
immunization. WHO’s function in individual countries varies widely, depending on country 















































capacity and need. At the global level, WHO focuses on setting norms, standards and policies, 
development of global guidance and global partner leadership and coordination. At regional 
and country level, WHO offices provide more direct technical assistance, operational support, 
guidance and intercountry coordination. In particular, WHO plays the following main roles in 
global immunization:
◆◆ setting policies and establishing norms for strengthening routine immunization;
◆◆  providing technical guidelines and resource materials for programme management and 
capacity strengthening;
◆◆  providing direct technical assistance to its 194 Member States through its six regional 
offices and staff located in 147 countries;
◆◆  under its mandate as convenor and global coordinator of health matters, measuring the 
progress in meeting the Decade of Vaccines routine immunization goals;
◆◆  convening immunization partners to collaboratively support immunization programmes 
and ensuring that all stakeholders are involved in planning implementation and reporting;
◆◆  overseeing the global monitoring, surveillance and feedback functions of immunization 
programmes, including collection of financial data to enable intercountry comparison 
and allow measurement and modelling of progress;
◆◆  supporting the oversight, accreditation and structure for maintaining assured-quality 
vaccine production;
◆◆  promoting immunization equity and universal access by facilitating civil society 
participation in government-led health planning and health system strengthening;
◆◆  gaining appropriate political commitment through WHO’s governing bodies such as 
the WHA.
UNICEF
UNICEF is mandated by the United Nations General Assembly to advocate for the protection 
of children’s rights, to help meet their basic needs and to expand their opportunities to reach 
their full potential.
For routine immunization, UNICEF:
◆◆  is the leading global agency for vaccine procurement for routine immunization and is 
responsible for buying vaccines and related items for global campaigns to eradicate 
polio, eliminate neonatal and maternal tetanus, and control measles and for new vaccine 
introductions with Gavi support;
◆◆  supports governments to create effective plans that target unimmunized children and 
provide for both the cost of vaccines and for their delivery;
◆◆  supports local health workers to create detailed plans with the aim of reaching every 
child – especially those living in underserved and remote areas;
◆◆  supports social mobilization efforts to engage communities and explain the importance 
of vaccination, using a tailored approach adapted to each local context. UNICEF works 
with community leaders, civil society organizations, health ministries and media to 
provide caregivers with reliable information on the safety, effectiveness and availability 
of vaccines;
◆◆  invests in cold and supply chain infrastructure and management to improve the 
conditions in which vaccines and other lifesaving health commodities are delivered;















































Technical partners (e.g. Centers for Disease Control  
and Prevention, PATH, John Snow, Inc.)
Technical partners support both Member States and WHO to:
◆◆  generate, synthesize and disseminate evidence on the effectiveness and comparative 
strength of interventions designed to improve immunization coverage and 
system processes;
◆◆  develop and implement monitoring and evaluation methods and tools for assessing the 
performance of immunization systems to further identify best practices and lessons 
learnt for programme implementation;
◆◆  invest in opportunities to further develop capacity of the immunization workforce in 
strengthening country-level planning activities, public health management, supervisory 
skills, immunization data management and data use for decision-making;
◆◆  identify and disseminate best practices for identifying opportunities to further efficiently 
integrate immunization systems into the broader health system to enhance the overall 
performance of the health sector;
◆◆  provide opportunities to develop, evaluate and implement innovative strategies that 
have the potential to positively impact the performance of immunization systems;
◆◆  support development of evidence-based immunization policies and programme 
implementation guidelines;
◆◆  support research and development of future vaccines, accelerate the introduction of 
existing vaccines and identify best practices for effective vaccine management.
Gavi, the Vaccine Alliance and the Gavi Secretariat
Gavi, the Vaccine Alliance, based in Geneva, Switzerland, is a global partnership established 
in 2000 bringing together public and private sectors with the mission of saving children’s 
lives and protecting people’s health by increasing equitable use of vaccines in lower-income 
countries. Members of Gavi include countries eligible for support, WHO, UNICEF, the World 
Bank, donor governments, the Bill and Melinda Gates Foundation, civil society organisations 
and others.
As a public–private partnership, the Gavi Alliance links its partners’ individual strengths, 
from WHO’s scientific expertise and UNICEF’s field presence and procurement system to the 
financial know-how of the World Bank and the market knowledge of the vaccine industry. The 
partners’ contributions to Gavi are coordinated by the Gavi Alliance Secretariat. The Alliance 
is governed by the Gavi Alliance Board to which all partners are held accountable. All partners 
invest in the Gavi business model. All are accountable for its results. Donors make long-term 
commitments to support Gavi, giving developing countries security to invest in their routine 
immunization programme and for manufacturers to plan new investments.
In addition to the individual roles and responsibilities that the Gavi Alliance partners have 
due to their mandate or function, the main roles of the Gavi Alliance are as follows.
◆◆  The Gavi Alliance works through existing in-country partners who in turn have widespread 
field presence to contribute to Gavi’s programme delivery. This keeps burdensome 
transaction costs down for implementing country governments. The Gavi Secretariat 
is not present on the ground in developing countries. Instead health ministries take 
the lead, working closely with WHO and UNICEF regional and country offices, which 















































◆◆  Gavi funds immunization programmes in developing countries where the vast majority 
of the world’s unvaccinated children live, and provides support to the strengthening of 
health systems to help ensure that vaccines reach people everywhere. All Gavi-supported 
countries co-finance a share of their vaccine costs. As their economies grow, they increase 
their investment in immunization and eventually sustain their own programmes. 
The availability of long-term, predictable funding for immunization coupled with 
aggregated country demand enables the vaccine industry to supply vaccines at more 
affordable prices.
◆◆  Gavi provides funding for vaccine procurement and delivery. Gavi relies on UNICEF’s 
supply division as its primary procurement agent to negotiate with suppliers, make the 
purchases and deliver the vaccines to countries. It provides financial support to country 
health systems in order to improve immunisation coverage and equity.
The Gavi Secretariat’s core functions include the following.
◆◆ Funding mechanism:
◆  Collecting and distributing donor pledges to support the Gavi Alliance mission and 
strategic goals;
◆  Convening review mechanisms for approving country grant requests for immunization, 
vaccines and health systems support.
◆◆ Policy coordination for Gavi support:
◆ Developing policy frameworks for Gavi support;
◆  Convening the Gavi Board, which approves Gavi programmes and policies and sets the 
agenda for immunization and health systems support;
◆  Facilitating the implementation of Partner Engagement Framework for Gavi Alliance.
◆◆ Coordination of implementation of Gavi support:
◆ Providing stewardship for new vaccine and finance support;
◆ Serving as focal point for country readiness for specific Gavi support.
◆◆ Co-financing:
◆ Monitoring Gavi policy of co-financing from all Gavi-supported countries;
◆  Working with Ministers of Health and Finance to promote sustainable funding 
mechanisms for immunization;
◆  Working with private sector and other partners on ensuring long-terms sustainability 
for immunization support (IFFIm, Matching Fund).
◆◆ Market shaping:
◆ Pooling demand for new vaccines among more than 50 countries;
◆ Working with partners to create new market shaping mechanisms like the AMC;
◆ Conducting strategic dialogue with vaccine manufacturers.
◆◆ Advocacy:
◆  Creating political will in donor and Gavi-supported countries to support immunization 














































Foundations, philanthropies and donor governments
Foundations and philanthropies can provide financial, technical and advocacy resources, but 
the ways in which they do so vary greatly as their governance ranges from family foundations 
to government institutions. At their best, they are flexible and can play traditional as well as 
unique roles in immunization. Illustratively, they can:
◆◆  provide “voice” and influence around conventional and exploratory approaches/issues, 
and spotlight and nurture visionaries, leaders, and successful ideas;
◆◆  invest in catalytic ideas, promote innovation, promising practices, new ways of working 
and doing, and advance knowledge and practice, including with high-risk endeavours;
◆◆  advance development of new vaccines/equipment and new delivery technologies, and 
anticipate future needs;
◆◆  support and expand the scale of existing proven approaches, and respond swiftly to 
changing contexts of what is working and what is not (in collaboration with partners, 
communities and grantees);
◆◆  amplify and advance investments in health systems building systems to assure last-mile 
reach and equity;
◆◆  increase available resources via donor networks and building business cases for donors;
◆◆  support the capacity building of partners and implementing organizations 
around immunization;
◆◆  develop innovative financing mechanisms that increase sustainability of programmes 
and provide incentives for actions that benefit the public good (e.g. outcome investing, 
co-financing agreements and basket funds);
◆◆ tackle complex problems when a longer time horizon might be needed.
Civil society organizations, including nongovernmental organizations
Civil society organizations are engaged to:
◆◆  work with governments and immunization partners in countries to connect communities 
to immunization and health services;
◆◆  hold governments and immunization partners accountable to the population served 
for immunization;
◆◆  raise awareness of the benefits of immunization and the right to health at the community 
and country level;
◆◆  increase the demand for immunization and health services within 
underserved communities;
◆◆ mobilize communities to appropriately use immunization services;
◆◆ deliver immunization services in cooperation with governments;
◆◆  advocate for integrated service delivery and health services that respond to 
community needs;
◆◆  provide information and encouragement to families of vaccination drop-outs 
and refusers;
◆◆  participate in national, subnational and community immunization planning, monitoring 
and reporting;
◆◆  encourage government transparency and accountability;
◆◆ represent vulnerable and marginalized populations at the national policy level;
◆◆ influence policy creation at the national, regional and global level;
◆◆  support domestic and international resource mobilization and allocation for 
immunization and health system strengthening.
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